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Introduction
Tissue vascularization and angiogenesis represent essential 
processes by which organs obtain appropriate blood supply and 
nutrients under physiological conditions. In contrast, many dis-
eases are associated with dysfunctions of these processes. In 
particular cancer growth and metastasis are strictly dependent 
on tumor vascularization, which is promoted by the tumor cells 
themselves through the secretion of several growth factors.
Endothelial cell (EC) adhesion and migration are critical 
steps of the angiogenic process, in which activated ECs, led by 
tip cells, migrate toward a chemoattractant angiogenic signal 
consisting of growth factors that are secreted by tumor cells 
and their stroma and give rise to an integrated vascular network 
(Potente et al., 2011). In this process, EC adhesion to provi-
sional ECM proteins such as fibronectin (FN) is mediated by 
α5β1- and αv-containing integrin receptors, which cooperate in 
remodeling the vasculature during angiogenesis (Serini et al., 
2006; van der Flier et al., 2010). Small G proteins belonging to 
the Ras-associated protein (Rap) branch of the wider Ras super-
family have been implicated in a variety of integrin-mediated 
“inside-out” signaling events (Reedquist et al., 2000; Lafuente 
et al., 2004; Chrzanowska-Wodnicka et al., 2008; Carmona et 
al., 2009). By themselves, Ras superfamily proteins are small 
G proteins that cycle between inactive GDP-bound forms and 
active GTP-bound forms (Bourne et al., 1990). Exchange for 
GTP and hydrolysis of GTP to GDP are catalyzed by guanine 
nucleotide exchange factors and GTPase-activating proteins, re-
spectively (Gloerich and Bos, 2011).
Endothelial cell adhesion and migration are critical steps of the angiogenic process, whose dysfunction is associated 
with tumor growth and metastasis. The TRPM8 channel has recently been proposed to play a protective role in prostate 
cancer by impairing cell motility. However, the mechanisms by which it could influence vascular behavior are unknown. 
Here, we reveal a novel nonchannel function for TRPM8 that unexpectedly acts as a Rap1 GTPase inhibitor, thereby in-
hibiting endothelial cell motility, independently of pore function. TRPM8 retains Rap1 intracellularly through direct pro-
tein–protein interaction, thus preventing its cytoplasm–plasma membrane trafficking. In turn, this mechanism impairs the 
activation of a major inside-out signaling pathway that triggers the conformational activation of integrin and, conse-
quently, cell adhesion, migration, in vitro endothelial tube formation, and spheroid sprouting. Our results bring to light 
a novel, pore-independent molecular mechanism by which endogenous TRPM8 expression inhibits Rap1 GTPase and 
thus plays a critical role in the behavior of vascular endothelial cells by inhibiting migration.
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Another set of molecules that are increasingly recognized 
to play an active role in cell migration and tumor vasculariza-
tion are ion channels, through changes in their expression and/
or activity (Schwab et al., 2012; Fiorio Pla and Munaron, 2014). 
In this context, the discovery of the transient receptor poten-
tial (TRP) superfamily of channels has provided candidates for 
nonvoltage gated Ca2+ entry mechanisms and their participation 
in different cellular processes. During the past 20 yr, numer-
ous studies have indicated that the expression and/or activity 
of TRP channels are in fact altered in cancers. In particular, the 
presence of the TRPC, TRPM, and TRPV subfamilies is cor-
related with malignant growth and cancer progression (Gkika 
and Prevarskaya, 2009; Prevarskaya et al., 2010). As such, TRP 
channels have been proposed as biomarkers for the diagnosis 
or prognosis of cancer progression, and targeting TRP channels 
has been suggested as a novel therapeutic strategy (Thebault 
et al., 2006; Nilius, 2007; Ding et al., 2010; Gkika and Pre-
varskaya, 2011). TRP channels are expressed in ECs, and their 
functions have been related to critical steps of tumor vascular-
ization, such as cell migration and in vitro angiogenesis (Fiorio 
Pla et al., 2012a; Fiorio Pla and Gkika, 2013). In this regard, we 
unveiled how TRPV4 is overexpressed in tumor-derived ECs, in 
which it plays a key role in the control of cell migration (Fiorio 
Pla et al., 2012b). Moreover, increasing evidence demonstrates 
that ion channels are indeed pivotal regulators of directed cell 
migration. For example, Tsai et al. (2014) have recently pro-
posed an integrated model of the spatial organization of the 
STIM1–ORAI1 signaling system, which dynamically controls 
the polarization and persistence of migration as well as local 
adhesion and turning, together with the actin regulators Rac, 
Cdc42, RhoA, and PtdIns (3;4;5)P3.
Among TRP channels, the cold/menthol–sensitive 
TRPM8 (belonging to the melastatin TRP subfamily) has 
emerged as an important player in cell migration and tumor 
progression; its expression is strongly up-regulated in prostate, 
breast, colon, lung, pancreatic, and skin cancers. In contrast, 
TRPM8 expression is dramatically reduced during late cancer 
stages and during metastatic dissemination in androgen-inde-
pendent prostate cancer (Tsavaler et al., 2001; Henshall et al., 
2003; Gkika and Prevarskaya, 2009; Yee et al., 2010; Grolez 
and Gkika, 2016). It has recently been proposed that TRPM8 
could have a protective function in metastatic prostate cancer by 
impairing the motility of these cancer cells (Gkika et al., 2015, 
2010). Conversely, apart from a very few studies suggesting 
TRPM8 expression in vascular cells (Johnson et al., 2009; Mer-
gler et al., 2013; Sun et al., 2014), no information is available 
regarding its possible expression in tumor-derived ECs and its 
involvement in EC migration.
Here, we investigated the role of the TRPM8 channel in 
ECs and demonstrate that it inhibits EC adhesion, migration, 
spheroid sprouting in vitro, and self-assembly into a vascular net-
work via a novel and completely unexpected role as a Rap1 GT-
Pase inhibitor that controls β1-integrin–mediated EC behavior.
Results
Endogenous TRPM8 is expressed in ECs
TRPM8 expression was investigated in different types of 
ECs, namely human umbilical vein ECs (HUV ECs), human 
umbilical artery ECs (HUA ECs), human microvascular ECs 
(HMECs), and human breast tumor-derived ECs (BTECs). A 
single major band of 95–100 kD was detected in all EC types 
tested (Fig. 1 Ai), consistent with previously reported intracel-
lular TRPM8 (Bidaux et al., 2007; Wondergem et al., 2008). As 
expected, the classic 130-kD TRPM8 form was clearly present 
in positive-control lysates obtained from HEK-293 cells with 
inducible TRPM8 expression (HEK-TRPM8 cells; Bidaux et 
al., 2007) but absent in ECs (Fig. 1 Bi). The intracellular local-
ization of TRPM8 protein in ECs was confirmed by means of 
cell surface biotinylation assays; no TRPM8 expression was de-
tected in the biotinylated surface fraction of ECs in the presence 
or absence of 10 µM of specific agonist icilin (for 10 min) when 
compared with HEK-TRPM8 cells used as positive controls, 
whereas TRPM8 was equally expressed in total cell lysates of 
both HMECs and HEK-TRPM8 cells (Figs. 1 Bi and S1 A). 
Similarly, confocal immunofluorescence analyses showed the 
colocalization of endogenous TRPM8 with the ER marker cal-
nexin (Fig. 1 Bii). Interestingly, BTECs showed lower TRPM8 
mRNA and protein levels than normal ECs (Fig. 1 Aii), further 
confirming the different expression pattern of Ca2+-related pro-
teins in BTECs compared with normal ECs (Fiorio Pla et al., 
2008, 2010, 2012b; Pupo et al., 2011).
Constitutive TRPM8 inhibits EC migration, 
in vitro sprouting, and in vitro vascular 
network formation independently of channel 
pore function
Having assessed the presence of TRPM8 in ECs, we next inves-
tigated the possible role of TRPM8 in the control of the forma-
tion of capillary-like structures and vascular networks by 
cultured ECs. To this end, we first studied EC migration by 
means of wound-healing assays. HMEC and HUV EC stimula-
tion with 10  µM icilin or 250  µM menthol progressively de-
creased their migration rate, with this difference becoming 
significant starting at 4 h (Fig. 1, Ci and Cii; and Fig. S1 Bi). No 
significant effect was detected in BTECs (Fig. 1 Cii) in accor-
dance with the low levels of TRPM8 expression in this EC type. 
We previously described the role of PSA as an endogenous 
TRPM8 activator responsible for prostate cancer inhibition of 
cell migration (Gkika et al., 2010). We therefore studied here 
the role of PSA in EC migration to test the hypothesis of a com-
mon endogenous regulator of TRPM8-mediated cell migration. 
Indeed, 40 ng/ml PSA treatment significantly reduced EC mi-
gration starting from 4  h similarly to 10  µM icilin treat-
ment (Fig. 1, Ci and Ciii).
To confirm the role of endogenous TRPM8 in modulat-
ing EC migration, we repeated wound-healing assays after the 
specific silencing of the channel using siRNAs in both HMEC 
and HUV ECs. After 72  h of transfection, TRPM8 silencing 
was monitored at the protein level by immunoblot analysis, and 
found to be significantly decreased in HMEC and HUV ECs (by 
60% and 50%, respectively; Fig. S1 C). Interestingly, silencing 
of endogenous TRPM8 in ECs was sufficient to promote a sig-
nificant increase in the migration rate in both HMECs and HUV 
ECs starting from, respectively 4 h or 6 h, suggesting a basal 
role of the channel in the control of EC migration (Fig. 2 A). 
Consistent with these results, TRPM8 overexpression in BTECs 
significantly inhibited cell migration even in the absence of 
10 µM icilin (Fig. 2 B).
We next investigated the effective role of ion fluxes gen-
erated by TRPM8 on cell migration. For this purpose we per-
formed wound-healing experiments overexpressing a TRPM8 
construct that carry a single point mutations in TRPM8 pore 
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region (Y905A) which completely inhibits channel activity as 
recently characterized (Bidaux et al., 2015). Interestingly, when 
transfecting BTECs with TRPM8Y905A, EC migration was sig-
nificantly inhibited, even in the absence of channel agonist, to 
an extent similar to wild-type TRPM8 overexpression (Fig. 2, 
Bi and Bii). These data demonstrate that the biological effects 
of TRPM8 on EC migration described here are not imputable to 
the pore function of the TRPM8 protein.
Figure 1. (Ai) Western blot analysis of TRPM8 protein levels in HMECs, HUV ECs, and HUA ECs. (Aii) Analysis of TRPM8 mRNA expression by qPCR levels 
and protein expression in HMECs and BTECs. For quantitative PCR, data were normalized to 18S rRNA. Data are mean ± SEM of three different experi-
ments. (B) TRPM8 in HMECs is expressed on the ER. (Bi) Surface biotinylation experiment performed on HMECs and HEK cells overexpressing TRPM8 
(HEK-TRPM8 cells). (Bii) Representative confocal images of HMECs showing DAPI staining (blue), calnexin (green), and TRPM8 (red) immunolabeling; the 
merged image shows the colocalization of endogenous TRPM8 with calnexin, indicating intracellular TRPM8 localization. (C) TRPM8 stimulation inhibits 
the migration of normal, but not tumor, ECs. (Ci) Representative photographs of a wound-healing assay performed on HMECs treated with control medium, 
10 µM icilin, or 40 ng/ml PSA taken at two different time points (t = 0 h, top; t = 8 h, bottom). Bars, 50 µm. (Cii) Plot of the percentage of migration of 
BTECs (red), HMECs (black), and HUV EC (green) under control conditions (growth medium) or treated with 10 µM icilin. (Ciii) Plot of the percentage of 
migration of BTECs (B in red) and HMECs (H in black) under control conditions (growth medium) or treated with 40 ng/ml PSA. *, P < 0.05 for comparisons 
between cells of the same type treated with or without icilin (Cii) or PSA (Ciii).
[AQ13]
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Figure 2. TRPM8 inhibits EC migration independently of the channel’s pore function. (Ai) Plot of the percentage of migration in the wound area of silenced 
HMECs (siTRPM8 in gray and CNT RL in black). (Aii) Plot of the percentage of migration in the wound area of silenced HUV ECs (siTRPM8 in gray and CNT 
RL in black). (Bi) Representative photographs of a wound-healing assay taken at two different time points (t = 0 h, top; t = 8 h, bottom). BTECs transfected 
with 2 µg of a GFP control vector (CNT RL), 2 µg TRPM8, or TRPM8Y905A were treated with control medium or 10 µM icilin. Bars, 50 µm. (Bii) Plot of the 
percentage of migration of BTECs overexpressing TRPM8 (TRPM8, in gray) TRPM8Y905A (TRPM8Y905A, in red; TRPM8Y905A + icilin, in green) or GFP as a 
control (CNT RL, in black). §, significant difference relative to control. (C) TRPM8 inhibits in vitro vascular network formation. (Ci) Quantification of tubulo-
genesis in HMECs silenced for TRPM8 (HMEC/siTRPM8) or not (HMECs). (Cii) Quantification of tubulogenesis of BTECs overexpressing TRPM8 (BTEC/
TRPM8) or not (BTECs). *, P < 0.05. (D) TRPM8 inhibits EC in vitro sprouting. Representative bright-field micrographs of control (CNT RL) or VEGF-stimulated 
(VEGF) EC spheroids, in the presence or absence of 10 µM icilin showing reduced vascular sprouting in spheroids. Bars, 50 µm. The bar graphs show 
quantification of EC spheroid sprouting area, revealing that stimulation of TRPM8 by icilin reduced the sprouting area. *, P ≤ 0.05; **, P 
≤ 0.01; ***, P ≤ 0.001.
[AQ14]
[AQ15]
TRPM8 controls migration via Rap1–β1-integrin pathway • Genova et al. 5 of 33
ROUGH GALLEY PROOF
To further investigate the biological roles of TRPM8 in 
ECs, we studied in vitro vascular tubulogenesis by exploiting 
the permissive properties of Matrigel. In icilin- or menthol-stim-
ulated ECs, we observed a strong reduction in their ability to 
self-assemble into interconnected tubules in Matrigel, which 
was prevented by TRPM8 silencing (Figs. 2 Ci and S2 B). Con-
versely, and as expected, icilin treatment did not affect the abil-
ity of BTECs to form vascular networks. Remarkably, TRPM8 
overexpression in BTECs promoted a substantial reduction in 
tubule formation, even in the absence of external activators, 
suggesting a basal role of the channel in the control of both 
EC migration and in vitro vascular morphogenesis (Figs. 2 Ciii 
and S2 B). Notably, exogenous TRPM8 is likely localized at 
both the intracellular and PM levels, as also confirmed by Ca2+ 
imaging and electrophysiological recordings (Fig. S4, A and B).
Finally, to study the role of TRPM8 on vessel sprouting, 
we performed HUV EC spheroid sprouting assays. TRPM8 is 
critically involved in vitro EC sprouting, as icilin treatment 
significantly decreased the sprouting area after 24 h treatment, 
both in the basal condition and in VEGF-stimulated spheroids 
(n = 60 spheroids per experimental condition; Fig. 2 D).
TRPM8 inhibits EC adhesion
The dynamic control of cell-to-ECM adhesion is a fundamental 
aspect of EC migration and vascular morphogenesis (Serini et 
al., 2006; Francavilla et al., 2009). We therefore tested the hy-
pothesis that the inhibition of EC migration by TRPM8 could 
be caused by an impairment in the ability of cells to adhere to 
the ECM. We acutely treated adherent ECs with 10 µM icilin 
and, using time-lapse video microscopy, we observed that 77% 
of the analyzed cells immediately rounded up upon TRPM8 ac-
tivation (n = 52 cells; Fig. 3 Ai) To better quantify this effect, we 
took advantage of an impedentiometric system that can moni-
tor over time the spread of cultured cells using electrical im-
pedance as a readout. We found that, compared with untreated 
control conditions, icilin stimulation reduced EC adhesion and 
area of spread, with a peak effect at 10 min of treatment (Fig. 3 
Aii); subsequently, ECs began to respreads, although they still 
displayed lower adhesion and spread compared with untreated 
control ECs (Fig. 3 Aii, inset graph).
This cell rounding-up effect was supported by a multi-
scale hybrid mathematical approach (Fig. S3, A and B) based 
on the cellular Potts model (CPM) framework (Graner and 
Glazier, 1992; Glazier and Graner, 1993; Scianna et al., 2013), 
which allows the description of cell adhesion and migration as 
well as the underlying molecular dynamics to be described. As 
shown in Fig. 3 B, the results of the mathematical simulation 
were in agreement with “wet” experiments, displaying a similar 
shrinkage effect in the presence of the TRPM8 agonist icilin 
(Fig. 3 Bi). Remarkably we observed that basal TRPM8 chan-
nels in the absence of external agonist was sufficient to pro-
mote a rounding-up effect in virtual cells in the mathematical 
model (Fig. 3 Bii). The model also confirmed that TRPM8 ex-
pression significantly reduced cell migration speed and random 
cell velocity, in accordance with the aforementioned migra-
tion assays (Fig. S3 C).
Model prediction of TRPM8 
cellular location
Taking advantage of the flexibility of our mathematical ap-
proach, we decided to further characterize the significance of 
the subcellular localization of TRPM8 for its function. Although 
TRPM8 in ECs is intracellular, localization at the plasma mem-
brane (PM) has also often been described. We simulated the 
selective localization of TRPM8 either in intracellular compart-
ments (ER) or at the PM. Notably, mathematical model predic-
tions showed that when TRPM8 was exclusively localized at the 
PM, cell migration speed was strongly inhibited, to an extent 
largely identical to that observed when TRPM8 was localized 
exclusively at the ER (Fig. S3 D). We then simulated different 
levels and different ER/PM ratios of TRPM8 expression. Inter-
estingly, the modeled outcomes clearly predict that cell behav-
ior is significantly affected by the overall level of TRPM8, but 
not by its subcellular localization. In fact, as indicated in Fig. 
S3, variations in the ER/PM ratio did not significantly alter cell 
migratory determinants. It should be noted that the in silico ap-
proach allows the subcellular localization of TRPM8 to be pre-
cisely defined, something that cannot be achieved in living cells, 
in which a fraction of the channel is likely trapped in the ER at 
all times. However, the results obtained by our mathematical 
approach were supported by cell migration assays performed 
under comparable experimental conditions, i.e., with HMECs 
that did not express any detectable TRPM8 at the PM (Figs. 1 C 
and 2 A) and with BTECs in which TRPM8 was overexpressed 
(Fig. 2 B) and likely localized both at the intracellular and PM 
levels, as also confirmed by the transient and sustained phase in 
Ca2+ imaging experiments and electrophysiological recordings 
in the latter cells (Fig. S4, A and B)
TRPM8 inhibits EC adhesion by 
negatively interfering with inside-out β1-
integrin signaling
To better characterize the molecular mechanisms by which 
TRPM8 controls EC adhesion to the ECM, we next performed 
adhesion assays on ECs seeded on increasing concentrations of 
FN. There was a progressive increase in the number of adherent 
cells with increasing FN concentrations, suggesting a role for 
α5β1 integrin in EC adhesion (Figs. 3 C and S5 A). Moreover, 
icilin stimulation promoted a substantial reduction of EC adhe-
sion to FN, regardless of the concentration of the latter (Figs. 
3 C and S5 A); similar results were obtained in the presence 
of menthol (Fig. S1 Biii). To substantiate the role of α5β1 in-
tegrin in TRPM8-mediated EC inhibition, we next performed 
haptotaxis assays, in which ECs were induced to directionally 
migrate toward surface-bound 1 µg/ml FN; TRPM8 stimulation 
did not have any effect on EC migration in the absence of the 
surface-bound haptotactic stimulus but significantly inhibited it 
in the presence of FN (Figs. 3 D and S5 B).
The specificity of TRPM8 and its role in controlling cell-
to-ECM adhesion was further assessed by specific channel si-
lencing, which prevented the icilin-driven inhibition of HMEC 
or primary HUV EC adhesion to FN (Fig. 3, E and F; and Fig. 
S5, C and D). Conversely, TRPM8 overexpression in BTECs 
(Figs. 3 G and S5 E) or even in HMECs (Fig. S4 C) significantly 
reduced the relative percentage of adherent cells to FN, with or 
without icilin treatment
To directly verify the involvement of β1-integrin in the 
TRPM8-mediated signaling pathway, we performed adhesion 
assays in the presence of the β1-integrin antibody 9EG7 that 
recognizes and stabilize active β1-integrins (Lenter et al., 1993; 
Bazzoni et al., 1995). The addition of 9EG7 fully reversed 
TRPM8-mediated inhibition of relative percentage of adherent 
ECs to FN (Figs. 4 A and S5 F). These results clearly show that 
TRPM8 modulates EC adhesion to FN through the inactivation 
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of its major receptor, namely α5β1 integrin. Moreover, the res-
cue effect observed upon 9EG7-elicited β1-integrin activation 
indicates that TRPM8 effect in EC adhesion is likely caused by 
an inhibitory effect on the inside-out signaling pathways that 
control integrin activation. To better test this hypothesis, the 
activity of β1-integrin was evaluated in HUV ECs by means of 
immunofluorescence staining 9EG7 antibody for active β1-in-
tegrins. TRPM8 stimulation with 10 µM icilin clearly and sig-
nificantly inhibited the 9EG7 distribution in HUV ECs, with a 
maximal effect after 30 min treatment (n = 15 cells per experi-
mental condition; Fig. 4 C).
The involvement of FAK, a key downstream effector of 
β1-integrin–driven cell adhesion and migration, was evaluated 
by Western blot analysis. Compared with control ECs, stimula-
tion of TRPM8 by 10 µM icilin promoted a significant reduc-
tion in FAK autophosphorylation at the predominant Tyr 397 
phosphorylation site (Fig. 4 B).
Rap1 interacts with TRPM8 in ECs
Because our data suggested that TRPM8 could inhibit EC adhe-
sion to FN by impinging on the inside-out signaling pathways 
that promote integrin activation, we next decided to determine 
the molecular mechanisms responsible for this inhibition. Im-
munoprecipitation experiments did not show a convincing or 
robust interaction between endogenous or exogenous TRPM8 
and β1-integrins, suggesting the possible involvement of an 
intermediate molecule. We therefore took advantage of a GST 
pull-down assay using TRPM8 cytosolic tails as bait on ly-
Figure 3. TRPM8 stimulation inhibits cell 
adhesion. (Ai) Representative photographs 
showing the “rounding-up” effect induced by 
treatment with icilin for 10 min (right). (Aii) 
Quantification of cell adhesion area in HMECs 
treated with icilin (white circles) or not (black 
circles) and plated on FN. The experiment was 
performed using the XCellIgence-Roche appa-
ratus. The gray bar indicates values relative 
to the stage represented in Ai. (Bi) Simula-
tion of the rounding-up effect in a virtual cell 
expressing basal levels of 0.2  µM TRPM8, 
treated with icilin. (Bii) Evolution in time of the 
relative area of a simulated cell depleted of 
TRPM8 (CNT RL) or expressing basal levels of 
TRPM8 and treated with icilin (TRPM8+icilin) 
or not (TRPM8). The gray bar indicates val-
ues relative to the stage represented in Bi. (C) 
Quantification of adherent HMECs treated or 
not with 10 µM icilin on plates coated with 0, 
0.25, 0.5, and 1.0 µg/ml FN. *, P < 0.05. 
(D) Quantification of haptotaxis of HMECs 
treated or not with 10 µM icilin on 1 µg/ml FN 
or control substrate. *, P < 0.05. (E) Quantifi-
cation of adhesion to FN of HMECs silenced 
for TRPM8 (HMEC/siTRPM8) or not (HMEC), 
in the presence or absence of icilin. (F) Quanti-
fication of adhesion to FN of HUV ECs silenced 
for TRPM8 (HUV EC/siTRPM8) or not (HUV 
EC), in the presence or absence of icilin. (G) 
Quantification of adhesion to FN of BTECs 
overexpressing TRPM8 (BTEC/TRPM8) or not 
(BTEC), in the presence or absence of icilin. *, 
P < 0.05. All data in C–G represent adhesion 
normalized to the control untreated condition.
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sates of healthy mouse prostates to screen for candidate pro-
teins interacting with TRPM8 (for the full list of candidates, 
see Gkika et al., 2015).
Among the proteins interacting with TRPM8, our interest 
was drawn by Rap1, a small GTPase that is well known for its 
role as an effective integrin activator (Reedquist et al., 2000; 
Lafuente et al., 2004; Chrzanowska-Wodnicka et al., 2008; 
Carmona et al., 2009). Importantly, we confirmed the interaction 
between TRPM8 and Rap1 in intact cells by transiently 
expressing and then immunoprecipitating an HA-tagged wild-
type Rap1 (Rap1-WT) in inducible HEK-TRPM8 cells (Figs. 
5 A and S6 A). Similarly, Rap1-WT immunoprecipitated 
with TRPM8Y905A pore mutant proteins (Fig. 5 A), suggesting 
TRPM8 pore activity is not crucial for the interaction between 
the two proteins. We additionally studied the physical interaction 
between the endogenous TRPM8 and Rap1 and moreover 
localized the protein interaction complexes at the cellular level. 
We used the proximity ligation assay (PLA), which can detect 
protein–protein binding in situ at single-molecule resolution. 
PLA for Rap1 :TRPM8 produced abundant red puncta in 
HMECs that doubled upon treatment with icilin (Fig.  5  B), 
suggesting a stronger Rap1 :TRPM8 interaction. In addition, 
in HMECs activated or not with icilin, siRNA against TRPM8 
significantly decreased the puncta abundance, validating the 
specificity of the assay (n = 85 cells for control, n = 83 cells 
for the icilin treatment, and for the siTRPM8 the cell numbers 
were n = 91 and n = 93, respectively). No puncta were detected 
in control conditions (Fig. S5 G).
Further, to investigate which TRPM8 cytosolic tail is 
interacting with Rap1, we produced and purified the TRPM8 
N-terminal tail and C-terminal tail fused to GST (Fig.  5  C, 
inset). Pull-down of the GST-fused termini of TRPM8 with 
lysates of HEK cells overexpressing GFP-tagged Rap1-WT 
showed interaction of Rap1-WT mainly with the TRPM8 
N-terminal tail and to a lesser extent with the TRPM8 C-termi-
nal tail, whereas no interaction was observed with GST alone 
(Figs. 5 C and S6 B, left).
TRPM8 activation retains Rap1 
intracellularly, preventing its cytoplasm-PM 
trafficking
Given that TRPM8 and Rap1 interact, we next evaluated the 
dynamics of the TRPM8–Rap1 interaction in living ECs by 
means of confocal time-lapse recordings of ECs expressing 
GFP-Rap1-WT, TRPM8-YFP, and the ER marker ER-DsRed. 
In accordance with previously reported data (Bivona et al., 
Figure 4. TRPM8 inhibits EC adhesion through the Rap1–integrin–FAK pathway. (A) TRPM8 acts through the α5β1 integrin signaling pathway. Quan-
tification of adhesion to FN of HMECs treated (or not) with icilin, the integrin-activating 9EG7 antibody both in the presence of 0.1 mM MnCl2. Data 
represent adhesion normalized to the control untreated condition. (B) Western blot analysis of phosphorylated FAK (pY397 FAK) and total FAK protein 
levels in HMECs treated or not with 10 µM icilin for 10 min. Quantification of normalized pY397-FAK/FAK protein levels in HMECs from three independent 
experiments (bottom). (A and B) *, P < 0.05 (Wilcoxon–Mann-Whitney test). (C) Representative images showing anti–β1-integrin antibody 9EG7 (green) 
and DAPI (blue) in HUV ECs stimulated with for 15 or 30 min or untreated cells (t = 0). The bottom panel represents the same images binarized to better 
underlie the active β1-integrin organization. Bar graph on the right shows quantification of the corrected total cell fluorescence. *, P ≤ 0.05 (two-tailed 
heteroscedastic Student’s t test).
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2004; Carmona et al., 2009), GFP-Rap1-WT partially accumu-
lated at the PM, in particular at the leading edge of migrating 
ECs (Fig. 6 A). In contrast, TRPM8-YFP was localized in close 
proximity to ER-DsRed, similar to what was observed with en-
dogenous TRPM8 expression (Fig. 1 B).
The stimulation of migrating ECs with 10  µM icilin 
promoted a massive change in the subcellular localization of 
GFP-Rap1-WT characterized by its strong retention in close 
proximity to ER-localized TRPM8-YFP (Fig.  6 Aiii; n = 5 
cells). To quantify this retention effect, we measured the dis-
tance between GFP-Rap1-WT and TRPM8-YFP or ER-DsRed 
fluorescent signals, calculated from each plot profiles (see 
Materials and methods). Both Rap1-WT/ER and Rap1-WT/
TRPM8 distances significantly diminished starting 4 min after 
icilin application (Fig. 6, Bi and Bii, respectively, red and blue 
bars). Furthermore, the distance between GFP-Rap1-WT and 
the PM significantly increased during the same time period, 
thus confirming the intracellular retention of GFP-Rap1-WT 
(Fig.  6, Biii and Biv, black bars). As a consequence of the 
intracellular retention, ECs rounded up, decreasing the area 
they occupied, as shown by the reduction in GFP-Rap1-WT/
PM distance at later time points (Fig.  6 Biv, black bars), in 
accordance with the rounding-up effect induced by TRPM8 
stimulation (Fig.  3  A). Interestingly, GFP-Rap1-WT reten-
tion preceded the rounding-up effect (Fig. 6 Biv), suggesting 
that the latter could be functionally correlated with the loss of 
Rap1-WT-GFP from the PM.
To evaluate whether GFP-Rap1-WT retention was me-
diated by endogenous TRPM8, we then performed time-lapse 
confocal analyses of live ECs in which TRPM8 was silenced 
using siRNAs. As expected, GFP-Rap1-WT was retained intra-
cellularly after icilin stimulation in control ECs (n = 7/7 cells; 
Fig. 7, siCNT RL) whereas no significant effect was observed 
after icilin treatment in TRPM8-silenced ECs, in which GFP-
Rap1-WT continued to be largely associated with the PM (n = 
7/8 cells; Fig. 7, siTRPM8).
Figure 5. Rap1 is a TRPM8-interacting pro-
tein. (A) Representative immunoprecipitation 
experiments. Expression vectors encoding 
Rap1-WT-HA were transfected into HEK-over-
expressing TRPM8- or TRPM8Y905A-tagged 
cells. Cell lysates were immunoprecipitated (IP) 
with an anti–HA antibody and immunoblotted 
with antibodies against TRPM8 and HA. Im-
ages in C and D are representative of three 
independent experiments. (B) In situ detection 
of endogenous TRPM8/Rap1 interaction in 
HMECs. TRPM8/Rap1 complexes were moni-
tored using PLA using anti–TRPM8 and Rap1 
antibodies followed by staining with proximity 
probes, ligation, and localized rolling-circle 
amplification. HMECs silenced for TRPM8 (si-
TRPM8) or not (siCNT RL), in the presence or 
absence of 10  µM icilin (10 min treatment). 
Close locations between the two proteins were 
observed as red fluorescent dots and DA-
PI-stained nuclei as blue. (Bii) Puncta density 
quantified as mean ± SEM puncta per cell. *, 
P ≤ 0.05; **, P ≤ 0.001 (Student’s t test). (Ci) 
TRPM8 N-terminal tail (GST-Nt), C-terminal tail 
(GST-Ct), or GST were incubated with lysates 
of HEK cells overexpressing Rap1-WT-GFP, 
Rap1-N17-GFP, or Rap1-V12 and precipitated 
using GST. Western blotting was performed 
with anti–GFP antibody. One representative 
experiment of three is shown. (Cii) Quantifica-
tion of Rap1/TRPM8 tails normalized over the 
input *, P < 0.05 (Student’s t test). Inset shows 
a scheme representing GST-Nt and C-terminal 
tail purification. (D) GST pull-down assay of in 
vitro translated Rap1WT, Rap1-N17, or 
Rap1-V12 using FluoroTect and GST or GST 
fused to the GST-Nt or GST-Ct. 10% of the in 
vitro translated Rap1 were used for the input of 
the GST pull-down (top). Bodipy-FL-stained gel 
are shown for the expression of Rap1. (E) The 
GST pull-down assay was repeated by loading 
in vitro translated RAP1-WT with 1 mM GDP 
(left) or 0.1 mM GTP (right). Anti-GST or anti–
Rap1 antibodies were used to visualize the in-
teraction of Rap with GST-fused N- and 
C-terminal tail. All the gels are representative 
of at least three independent experiments.
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TRPM8 activation inhibits Rap1 activity by 
sequestering inactive Rap1
To study the endogenous activity of Rap1 on ECs, we per-
formed a new set of live-cell GTPase activity assays using the 
GFP-RBDRalGDS probe, a GFP-based probe designed to reveal 
when and where in the cell specific GTPases become activated 
(GTP bound; Bivona et al., 2004; Bivona and Philips, 2005). 
Spatiotemporal activation of endogenous Rap1 was studied in 
control and siTRPM8 transfected cells (Fig. 8 Ai). Membrane 
recruitment of GFP-RBD was quantified as direct indication 
for Rap1 activity caused by restricted localization of the active 
Rap1 pool at the PM; in particular, we measures the cytosolic 
retention fraction of GFP-RBD after icilin treatment (Bivona 
et al., 2004; Bivona and Philips, 2005; see also Materials and 
methods and Fig. S2 C). Our results clearly show that Rap1 
activation at the PM is significantly decreasing in the presence 
of icilin treatment (n = 18 regions of interest [ROIs], 5 cells; 
Fig. 8 A, siCNT RL; and Video 1) However, no significant effect 
was observed after icilin treatment in TRPM8-silenced cells, in 
which GFP-RBDRalGDS continued to be largely associated with 
the PM (n = 17 ROIs, 5 cells; Fig. 8 A, siTRPM8; and Video 2).
To investigate the functional effects of TRPM8 activation 
on Rap1 activity, we performed pull-down assays for GTP-
bound Rap1 using GST-RalGDS, which binds active Rap1-
GTP. Notably, after 10 µM icilin treatment, the amount of active 
Rap1-GTP protein present in HMECs significantly decreased 
by ∼50% as compared with control untreated HMECs or pri-
mary HUV ECs (Fig. 8 B). Rap1 activity in endogenous TRPM8 
was confirmed by pull-down assays on control (Fig. 8 B, siCNT 
RL) or TRPM8-silenced ECs (siTRPM8; both HMECs and 
HUV ECs), which did not show any significant Rap1-GTP de-
crease in the presence of 10 µM icilin treatment (Fig. 8 B). To 
study the effect of ion fluxes on Rap1 activity, we transfected 
HMECs with both TRPM8 or TRPM8Y905A pore mutant plas-
mids. Interestingly TRPM8 or TRPM8Y905A overexpression sig-
nificantly inhibited Rap1 activity at an extent similar to that of 
icilin treatment on HMEC control conditions; moreover, further 
treatment with icilin did not promote any additional inhibition 
Figure 6. TRPM8 activation leads to the in-
ternalization of Rap1. (Ai) Representative 
confocal time-lapse analysis of HMECs trans-
fected with GFP-Rap1 1 µg (green), TRPM8 
2 µg (blue), and ER-DsRed 1 µg to label the 
ER (red). On the right, the merged images are 
shown. (Aii and Aiii) Enlargements of the PM 
interface region displaying the internalization 
effect of TRMP8 activation on Rap1. The PM 
is shown by the dotted line in gray. On the 
right, the surface plot analysis is shown. (Bi 
and Biii) Plot profile of Rap1, ER, and TRPM8 
signals in HMECs under control conditions and 
after 10 min of treatment with 10  µM icilin. 
On the left is a photomicrograph of the cell in 
with a line indicating the cross section used 
for the plot profile. (Bii and Biv) Plots showing 
the means from a representative experiment of 
the distances measured between Rap1 and ER 
(red), between Rap1 and TRPM8 (blue), and 
between Rap1 and the PM (black) in HMECs 
under control conditions and after 10 min of 
treatment with 10  µM icilin. The distances 
were calculated as means of at least three dif-
ferent plot profiles for at least three regions of 
interest (cross sections) within each EC.
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of Rap1 activity (Fig.  9, Ai and Aii). These data confirm the 
pore-independent role of TRPM8. The functional effect of PSA 
treatment on Rap1 activity was studied by pull-down assays 
for active GTP-bound Rap1 using GST-RalGDS. Similarly to 
10 µM icilin treatment, 10-min treatment with 40 ng/ml PSA 
significantly reduced the amount of active GTP-bound Rap1 
(Fig. 9 B). These results suggest a correlation between PSA ac-
tivity and TRPM8-mediated EC inhibition via Rap1, thus sug-
gesting a possible role of PSA as an endogenous activator and 
common target for both cancer cells and ECs.
Interestingly, adhesion assays performed after trans-
fecting ECs with increasing amounts of the inactive N17 mu-
tant of Rap1 (van den Berghe et al., 1997; Reedquist et al., 
2000) showed that the inhibitory effect of TRPM8 activation 
on the number of adherent ECs was completely prevented by 
Rap1-N17 in a dose-dependent manner (Fig. 9 D), whereas no 
significant effect was observed when transfecting cells with 
the constitutively active Rap1-V12 mutant (Fig. S4 D). Nota-
bly, Rap1-N17 did not affect the basal adhesion of ECs to FN, 
whereas a significant increase in adhesion was observed in ECs 
transfected with Rap1-V12 (Fig. S4 E), in accordance with the 
data on Jurkat cell adhesion (Reedquist et al., 2000). Moreover, 
reintroducing TRPM8 in the presence of Rap1-N17 rescued the 
inhibitory effect of icilin in cell adhesion; icilin is again in fact 
able to inhibit the EC number of adherent cells starting from 
TRPM8 transfection with 0.5 µg plasmid (Fig. 9 E). The math-
ematical model reproduced this behavior in terms of migration 
velocity by predicting a saturation effect at sufficiently high 
doses of Rap1-N17 and a rescue of the inhibitory effect of icilin 
by TRPM8 activation (Fig. 9, F and G).
Based on the aforementioned findings, we hypothesized 
that TRPM8 could act as Rap1 inhibitor, retaining the GDP-
Figure 7. Intracellular Rap1 retention is pre-
vented by TRPM8 silencing in ECs. (A) Live-
cell imaging by confocal microscopy of ECs 
expressing GFP-Rap1 (green) and ER-DsRed 
(red) in control (siCNT RL) and siTRPM8-treated 
ECs (siTRPM8). Representative images show-
ing Rap and ER dynamics in siCNT RL- and 
siTRPM8-treated ECs at t = 0 and after 2 or 10 
min of treatment with 10 µM icilin; dotted white 
lines represent the PM. Representative plot 
profiles along the white lines in the images. 
The green bars depict the distance between 
the Rap1 and ER fluorescence signals. (B) Plot 
showing the means from a representative ex-
periment of the distances measured between 
Rap1 and ER between Rap1 and TRPM8 in 
control (siCNT RL) and siTRPM8-treated ECs 
treatment with 10  µM icilin. The distances 
were calculated as means of at least three dif-
ferent plot profiles for at least three ROIs (cross 
sections) within each EC.
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bound form of Rap1 and blocking its GDP-GTP exchange and 
normal ER–PM shuttling, thus resulting in the robust inhibition 
of Rap1 function. In the presence of an excess of Rap1-GDP 
(e.g., when Rap1-N17 is overexpressed in ECs), endogenous 
TRPM8 preferentially binds and sequesters it, allowing un-
bound endogenous Rap1 to become activated by exchanging 
GDP for GTP and thereby activating β1-integrin and resulting 
in the rescue of TRPM8-inhibited EC adhesion (Fig. 9 D). To 
verify this hypothesis, GTP-bound Rap1 pull-down assays were 
performed on ECs transfected with a Rap1-N17 overexpression 
plasmid. As shown in Fig.  9 C, the inhibitory effect of icilin 
on endogenous Rap1 was prevented when ECs were trans-
fected with the inactive Rap1 mutant Rap1-N17. This would 
suggest a preferential interaction of TRPM8 cytosolic tails 
with the Rap1-GDP form.
To assess this hypothesis, we first studied the interaction 
of the TRPM8 GST-fused proteins with cell lysates overexpress-
ing GFP-tagged Rap1-N17, and Rap1-V12. As for Rap1-WT, 
we detected a clear interaction between Rap1-N17 or Rap1-V12 
with the TRPM8 N-terminal tail (GST-M8N) and to a lesser 
extent with the TRPM8 C-terminal tail (GST-M8C), whereas 
no interaction was observed with GST alone (Fig. 5 Ci). After 
Figure 8. Endogenous TRPM8 inhibits Rap1 activity. (Ai) Live-cell imaging by confocal microscopy of ECs expressing GFP-RBDRalGDS probe in control (siCNT 
RL) and siTRPM8-treated ECs (siTRPM8). Representative images showing RBDRalGDS in siCNT RL- and siTRPM8-treated ECs at t = 0 and after 2 or 10 min of 
treatment with 10 µM icilin; the bottom parts of the figures represent enlargements of the inset (white lines) for each time point. (Aii and Aiii) Bar plot rep-
resenting quantification of GFP-RBD membrane recruitment calculated as cytosol translocation as described in the method section. *, P < 0.05 (Wilcoxon–
Mann-Whitney test). (Bi) Active Rap1 pull-down assay on HMEC or HUV EC silenced for TRPM8 (siTRPM8) or not (siCNT RL), in the presence or absence of 
icilin. (Bii) Quantification of the Rap1 activity normalized to HMEC siCNT RL or HUV EC siCNT RL condition. *, P < 0.05 (Wilcoxon–Mann-Whitney test).
[AQ17]
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Figure 9. TRPM8 activation promotes GDP-binding with Rap. (A–C) Active Rap1 pull-down assay on HMECs transfected with 1 µg control vector 
(HMEC-WT; A), 1 µg TRPM8, 1µg TRPM8Y905A, or 1µg Rap1-N17 (C) were treated or not with 10 µM icilin or 40 ng/ml PSA (B) for 10 min. Positive con-
trol: GTPγS; negative control: GDP. Lower bands refer to total Rap1. (Aii, Bii, and Cii) quantification of the Rap1 activity quantified as Rap1GTP over total 
Rap1 normalized to HMEC-WT condition (Aii) or untreated conditions (Bii and Cii). (D) Quantification of adherent EC to FN of HMECs transfected with 
0.7, 1.0, 1.6, and 2.5 µg Rap1-N17 or control vector, treated or not with 10 µM icilin. *, P < 0.05. The data show adhesion in the icilin-treatment group 
normalized to control conditions. (E) Quantification of adhesion to FN of HMECs transfected with 1 µg Rap1-N17 and/or 0.5 or 2 µg TRPM8, treated or 
not with 10 µM icilin. *, P < 0.05. The data show adhesion in the icilin-treatment group normalized to control conditions. (F and G) Quantification of the 
mean relative velocity of a virtual cell expressing basal 0.2 µM TRPM8, treated or not with icilin, after the addition of different amounts of Rap1-N17 and/
or of exogenous TRPM8. The values shown are means of 100 simulations. Error bars show standard deviations. The data show velocity in the icilin-treatment 
group normalized to control conditions.
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quantification, Rap1-N17 showed a significantly stronger inter-
action for the TRPM8 N- and C-terminal tail as compared with 
Rap1-WT; moreover, only TRPM8 N-terminal tail interacted 
significantly more with Rap1-V12 (Fig. 5 Cii). We then assessed 
the possible direct association of Rap1 proteins with TRPM8 
C termini, by translating Rap1-WT, Rap1-N17, and Rap1-V12 
in vitro with FluoroTect (Fig. 5 D). The subsequent GST pull-
down assay revealed that only the inactive Rap1-N17 mutant 
interacted with TRPM8 (Fig. 5 D). This result was further vali-
dated by repeating the GST pull-down assay, but this time using 
only the Rap1-WT loaded with an excess of 1 mM GDP or 100 
μM GTP. In line with the results obtained using the Rap1 mu-
tants, GDP-loaded Rap1-WT interacted with the N terminus of 
the TRPM8 channel, whereas no interaction was detected when 
overloading with GTP or with unloaded Rap (Fig. 5 E). Collec-
tively, the GDP-bound Rap1 (Fig. 5 E) as well as the GST-fused 
TRPM8 termini pull-down assays (Fig.  5  D) confirm the hy-
pothesis for a selective interaction affinity of TRPM8 for Rap1-
GDP. To strengthen the idea of a GTPase inhibitor–like effect 
of TRPM8 in sequestering inactive Rap1-N17, we performed 
a new set of time-lapse confocal experiments. We performed 
a double transfection of GFP-Rap1-WT or GFP-Rap1-N17 
together with ER-DsRed in ECs. Although GFP-Rap1-WT 
was localized at the PM, at the leading edge of migrating ECs 
(Fig. 10 A), GFP-Rap1-N17 was already localized intracellu-
larly (Fig. 10 B) instead of being internalized upon TRPM8 ac-
tivation by icilin. This effect was quantified by measuring the 
distance between GFP-Rap1-WT or GFP-Rap1-N17 and ER-
DsRed, as well as between GFP-Rap1-WT or GFP-Rap1-N17 
fluorescent signals and the cell border, as previously described 
(see Fig.  6 and 7). The GFP-Rap1-WT/ER-DsRed distance 
significantly diminished starting 2 min after icilin treatment. 
Concomitantly, the distance between GFP-Rap1-WT and the 
cell membrane increased, suggesting that GFP-Rap1-WT was 
effectively internalized (Fig. 10 Ci). However, when cells were 
transfected with GFP-Rap1-N17, no significant difference in 
the GFP-Rap1-N17/ER-DsRed or the GFP-Rap1-N17/PM dis-
tance was observed after icilin treatment (n = 6/7 cells, four 
independent experiments; Fig. 10 Cii).
These data indicate how TRPM8 could exert an inhibitory 
effect on Rap1 activity by sequestering Rap1-GDP in intracel-
lular compartments, likely the ER, thus inhibiting its localiza-
tion to and activation at the PM and consequently impairing the 
β1-integrin–dependent adhesion of ECs to and migration on FN.
Discussion
TRPM8 functional expression has been recently suggested 
in ECs (Johnson et al., 2009; Mergler et al., 2013; Sun et al., 
2014). Our data support TRPM8 expression in ECs by show-
ing not only TRPM8 protein expression in different EC lines 
but also its dramatic down-regulation in different clones of tu-
mor-derived ECs. We further show that the EC TRPM8 shows 
an intracellular distribution and exerts an inhibitory effect on 
integrin-dependent cell-to-ECM adhesion, migration, endo-
thelial tube formation, and in vitro sprouting. We therefore 
propose here a novel molecular mechanism by which TRPM8 
interacts with the small GTPase Rap1 preferentially in its GDP-
bound state, inhibiting its function and consequently impairing 
the activation of a major inside-out signaling pathway that is 
known to activate integrin and thus mediate cell adhesion and 
migration. The TRPM8 inhibitory role on cell migration is in 
accordance with previous data; it has recently been proposed 
that TRPM8 could have a protective function in metastatic 
prostate cancer by impairing the motility of these cancer cells 
(Gkika et al., 2015, 2010).
We show that ECs express TRPM8 intracellularly, local-
ized close to the ER (Fig. 1). The intracellular localization of 
TRPM8 has been previously observed, although its role has not 
been fully elucidated (Zhang and Barritt, 2006; Bidaux et al., 
2007; Wondergem et al., 2008). As shown by standard experi-
ments silencing endogenous TRPM8 or overexpressing exoge-
nous TRPM8 (Figs. 2, 3, and 5), we unveil how intracellular 
TRPM8 in ECs mimics the functional effects of classic surface 
TRPM8 on cell adhesion and migration. Our data are also sup-
ported by a modeling approach showing that cell adhesion and 
migration are strictly dependent on basal TRPM8 activity and 
on its expression levels rather than its localization (Fig. S3 and 
supplemental text). Importantly, we show that the expression 
and constitutive activity of TRPM8 are sufficient to exert its 
functional effects, inhibiting EC–ECM ad-
hesion and EC migration.
One of the more interesting novel findings of this paper is 
the pore-independent function of TRPM8 on both EC migration 
and Rap1 inhibition; indeed, using an engineered pore mutant 
TRPM8 channel, we still observed an inhibition of migration 
and Rap1 activity similar to that of wild-type TRPM8 (Figs. 2 
and 9). In contrast, we clearly show that the inhibitory effect on 
migration was activated by icilin or menthol, well known 
TRPM8 gating activators (Baez et al., 2014; Bidaux et al., 
2015). These data are surprising and raise questions about the 
possible effects of icilin and menthol on TRPM8 besides pore 
gating. Although a crystal structure of TRPM8 has not been re-
ported yet, the structure of TRPV1 has recently been resolved in 
distinct conformations (Cao et al., 2013). Interestingly the au-
thors showed that in the presence of toxins and capsaicin (which 
binds S1–S4 modules similarly to menthol for TRPM8) beside 
the movement in the outer pore and rearrangements in the lower 
gate, movement of the S4–S5 linker and S6 is also accompanied 
by lateral displacement of the TRP domain, which is in turn 
suggested as a point of structural integration that facilitates al-
losteric coupling between channel domains (Liao et al., 2013). 
These data could support the hypothesis that icilin and menthol 
promote conformational changes that are reflected in other 
functions of the channel besides gating.
Similar nonconductive roles for channel proteins have 
been described previously, and in particular, modulation of in-
tracellular pathways has been reconducted to enzymatic roles 
of channel proteins or conformational coupling with other pro-
teins, ultimately converging onto the transcriptional regulation 
of cancer-related genes. In contrast, there is mounting evidence 
for nonconductive roles for TRP channels proteins as regulators 
of cytoskeletal dynamics (Vrenken et al., 2015). As an example, 
TRPP1, also known as PKD1, displays a clear channel-indepen-
dent role in the regulation of focal adhesion turnover by inter-
acting with FAK and paxillin (Joly et al., 2006).
We show that the effect of TRPM8 is mediated by an 
inhibition of the inside-out signaling pathway that drives the 
activation of the β1-integrins as also supported by the inhibi-
tion of TRPM8-mediated decrease in cell adhesion by means of 
the specific rat monoclonal antibody 9EG7, which recognizes 
a cryptic epitope that is exposed only in the EGF2 domain of 
conformationally active β1-integrins (Fig.  4  A), and the dra-
[AQ3]
[AQ4]
14 of 33
ROUGH GALLEY PROOF
JCB
matic inhibition of β1-integrin activation, as detected by 9EG7 
(Fig.  4  C), in agreement with the important role played by 
β1-integrins in the control of EC adhesion and migration (Ser-
ini et al., 2006; Bussolino et al., 2009). Moreover, ion channels, 
including TRP channels, are known to modulate cell migration 
by directly or indirectly impinging on integrin-linked pathways 
(Pillozzi et al., 2007; Thodeti et al., 2009; Jacquemet et al., 
2016). Our findings on TRMP8 are in agreement with previous 
observations concerning other endogenous inhibitory signals, 
such as those elicited by semaphorins (Serini et al., 2003), that 
exert an essential permissive role in the execution of this com-
plex morphogenetic process, such as vascular morphogenesis, 
by inhibiting integrin-mediated adhesion of ECs to the ECM, 
allowing the de-adhesion necessary for vascular remodeling.
Figure 10. TRPM8 activation promotes internalization of Rap1 WT, but not Rap1-GDP. Live-cell imaging of ECs performed using confocal microscopy. 
Representatives pictures of ECs cotransfected with ER-DsRed and Rap1-WT-GFP 1 µg (Rap1WT; A) or Rap1-N17-GFP 1 µg (Rap1N17; B) at t = 0 and 
after 10 min of treatment with 10 µM icilin. Rap1 is labeled in green, ER is labeled in red, and PM is marked in gray. In the surface plot (on the right), it is 
possible to appreciate the colocalization of Rap1 and ER. We chose to label the ER for experimental simplicity, as we have previously demonstrated (Fig. 5) 
that TRPM8 is closely related to the ER in terms of localization and dynamics. (C) Histograms showing the means of the distances measured in plot profile 
between Rap1 and ER (red) and between Rap1 and the PM (gray) in ECs transfected with Rap1-WT and Rap1-N17.
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A major discovery of our study is the identification of the 
intracellular mechanism involved in TRPM8 function. Several 
studies have revealed that TRPM8-mediated intracellular func-
tions are regulated by partner proteins. In particular, we have 
recently described a whole list of intracellular proteins that 
interact with TRPM8, and we showed that the novel family 
of TCAF proteins mediates its inhibition of cell migration in 
prostate cancer cells (Gkika et al., 2015). Here, we focused on 
another TRPM8-partner protein that is part of the recently pub-
lished list (Gkika et al., 2015) and revealed a novel Rap1-de-
pendent molecular mechanism by which TRPM8 inhibits 
β1-integrin function in ECs (Fig. 4). Rap1 is indeed a key player 
in the signaling pathways that drive integrin activation in several 
cell types, including ECs (Bos, 2005; Boettner and Van Aelst, 
2009). Here, we provide compelling evidence that its interac-
tion with TRMP8 affects Rap1 function and localization. In this 
regard, it has previously been reported that the steady-state dis-
tribution of Rap1 depends on its guanine nucleotide–binding 
state; in particular, GTP-bound Rap1 is up-regulated at the PM 
in conjunction with its activation, whereas the nucleotide-free 
form of Rap1 is observed on cytoplasmic vesicles, but not at the 
PM (Bivona et al., 2004).
Upon the further stimulation of TRPM8 by icilin, we ob-
served the intracellular retention of Rap1, which is therefore 
no longer able to shuttle from the ER to the PM; this retention 
is consistent with its close intracellular localization with both 
TRPM8 and the ER (Figs. 6 and 7). Moreover, the intracellular 
retention of Rap1 by TRPM8 inhibits Rap1-GTP loading and 
activation both in live cells as well as in vitro (Figs. 8 and 9). We 
therefore propose a model in which TRPM8 exerts an inhibitory 
effect on Rap1-GTP loading and functional activation by se-
questering the GDP-bound inactive form of Rap1, thus decreas-
ing the amount of Rap1 that is available for cycling from the 
inactive to the active form (GTP bound and on the cell surface). 
This function of TRPM8 ultimately results in the inhibition of 
integrin activity, thus leading to the inhibition of EC adhesion 
and migration. This hypothesis is supported by different evi-
dences: first, the direct interaction between Rap1 and TRPM8 
N- and C-terminal tails is clearly detectable in the presence 
of GDP-loaded Rap1-WT or inactive GDP-bound Rap1-N17 
mutant, but not with unloaded or GTP-loaded Rap1-WT 
(Fig. 5). Second, Rap1 activity is strongly increased by TRPM8 
down-regulation (Fig. 8). Finally, the saturation of TRPM8-Rap 
interaction sites in cells overexpressing the inactive GDP-bound 
Rap1-N17 mutant on Rap1 activity as well as on cell adhesion, 
which can in turn be reversed by overexpressing TRPM8 in ECs 
(Fig. 9). Indeed, the excess of Rap1-N17 mutant in these cells 
binds to and eventually saturates TRPM8, thus allowing endog-
enous Rap1 to be cycled to Rap1-GTP and resulting in β1-inte-
grin activation and EC adhesion and migration.
It is known that TRPM8 channels, like most TRP channels, 
are modulated by G proteins, as is the case for the Gi-coupled 
α2A-adrenoreceptor, which inhibits TRPM8 activity (Baven-
coffe et al., 2010). A direct interaction between TRPM8 and G 
proteins has recently been described. Zhang et al. (2012) have 
demonstrated that the G protein Gαq directly binds to and in-
hibits TRPM8; moreover Gαq binds to TRPM8 even when inac-
tive, and this binding is not enhanced by the activation of Gαq, 
supporting our hypothesis of TRPM8-Rap1–inactive binding. 
Conversely, another recent study has reported an interaction be-
tween TRPM8 and Gαq, showing that the activation of TRPM8 
causes the downstream activation of the metabotropic glutamate 
receptor–Gαq-PLC pathway (Klasen et al., 2012). This study 
supports our data and raises the possibility not only that G pro-
teins influence the gating of TRPM8, as previously shown, but 
also that TRPM8 gating may also influence G proteins and small 
G proteins such as Rap1, as we have shown here. In contrast, the 
interaction between Rap1 and the transmembrane proteins has 
recently been shown; semaphorin-mediated plexin dimeriza-
tion locally inhibits Rap activity. In particular, these findings 
connect transmembrane protein signaling to Rap-mediated sig-
naling, showing how small GTPases are used for spatial and 
temporal control of cell behavior (Wang et al., 2012). Our data 
suggest that TRPM8 could act similarly to a GDI-like protein, 
sequestering and inhibiting Rap1. Interestingly, in contrast to 
the classic GTP/GDP switch that regulates GTPase activity, an 
alternative nonconventional GDI mechanism mediated by the 
14-3-3 proteins has recently been described to inhibit Rap1 and 
other small GTPase proteins, facilitating their extraction from 
their site of action in membranes and keeping them inactive by 
sequestration in the cytoplasm (Riou et al., 2013). Moreover, 
Lilja et al. (2017) recently reported an unexpected Ras-binding 
domain in SHA NK3 protein that acts as an integrin activation 
inhibitor by sequestering active Rap1 and R-Ras via the SPN 
domain and thus limiting their bioavailability at the PM. Along 
these lines, our work uncovers a new role for the TRPM8 chan-
nel in ECs, where it act as a transmembrane Rap1 inhibitor that, 
by sequestering Rap1 at the ER, hinders its activation and its 
translocation to the cell surface, ultimately impairing β1-integ-
rin activation, cell adhesion, migration, and spheroid sprouting.
Although the present paper is mainly focused on vascu-
lar EC, TRPM8–Rap1 interaction and function is not confined 
to this particular type of cells but is crucial and generalized. 
In particular, we showed that TRPM8-Rap1native interactions 
are clearly detected in a prostate cancer sample (as presented 
in the interactome protein list reported by Gkika et al., 2015), 
where TRPM8 plays a similar role in cell migration as in ECs; 
in contrast, we confirmed GST pull-down in an overexpres-
sion system of HEK cells.
The identity of the endogenous TRPM8 activator still needs 
to be fully identified. However, we provide evidence that PSA 
inhibits migration of ECs and significantly reduces the amount of 
active Rap1-GTP bound similarly to icilin treatment. These data 
are in agreement with the role for PSA in prostate cancer cell mi-
gration via TRPM8 activation previously described by us (Gkika 
et al., 2010). In particular we suggested that the activity of PSA 
on TRPM8 channels was not direct by mediated by bradykinin 2 
receptor (Gkika et al., 2010) and therefore can act also on the ER 
form of the channel, which is the one present in ECs. Moreover, 
the antiangiogenic role of PSA has been reported by several 
groups in vitro and in vivo and is not dependent on its proteolytic 
activity (Fortier et al., 2003; Chadha et al., 2015). Collectively, 
our results reveal a new role for TRPM8 as a Rap1 inhibitor that 
arrests EC migration, whereas this effect could be regulated by 
PSA, an endogenous activator of the channel in vivo.
Materials and methods
Cell culture
We used BTECs, HMECs, HUV ECs, HUA ECs, and HEK- 293 cells 
with inducible TRPM8 expression (HEK-TRPM8).
BTECs were obtained from human breast lobular-infiltrating car-
cinomas and were isolated with an anti-CD105 antibody coupled to 
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magnetic beads by magnetic cell sorting using the MACS system 
(Miltenyi Biotec) as previously described (Bussolati et al., 2003; 
Grange et al., 2006). BTECs were isolated and extensively character-
ized by B. Bussolati (Grange et al., 2006). In particular, cell prepara-
tions of BTECs were obtained from four different tumors. All BTECs 
were characterized for EC marker expression. To dispel the possibility 
that contaminating tumor cells may influence our results, the B-TEC01 
cell line was cloned by limited dilution and obtained and characterized 
six different clones. All these clones confirmed the same pattern of en-
dothelial marker expression as the progenitor B-TEC01 cell line. One 
of those clones was used in the present paper.
HMECs were obtained from the derma using an anti-CD31 
antibody and MACS. HMECs from the derma were immortalized 
by the infection of primary cultures with a replication-defective 
adeno-5/SV40 virus as previously described (Cassoni et al., 2006; 
Fonsato et al., 2008). Both BTECs and HMECs were grown in com-
plete EndoGRO-MV-VEGF (EMD Millipore) supplemented with 50 
µg/ml gentamicin (Cambrex). Cells were used at passages 3 to 15. 
BTECs were cultured on a coating of 1% gelatin. Periodically, cells 
were characterized by their morphology and expression of a panel 
of endothelial antigens such as CD105, CD31, Muc-18 (CD146), 
CD44, and VEGF receptor 2.
HUV ECs and HUA ECs were isolated from the umbilical cord 
(from G. Serini’s laboratory; see Sandri et al., 2012) and growth in 
M199 medium completed with cow brain extract, heparin sodium salt 
from porcine intestinal mucosa (0.025 mg/500 ml), penicillin/strepto-
mycin solution, and 20% FBS (Sigma-Aldrich). HEK-293 and HEK-
TRPM8 cells were grown in DMEM (Invitrogen) supplemented with 
10% FCS (Poly-Labo; Seromed), 5 mM l-glutamine (Sigma-Aldrich), 
and 100 mg/ml kanamycin (Sigma-Aldrich). Cell were cultured as de-
scribed in (Thebault et al., 2005b).
Gene silencing and overexpression
Gene overexpression in HMECs, BTECs, and HEK cells was ob-
tained by nucleofecting 0.5–1.0 × 106 cells with the electropo-
rator Amaxa Nucleofector II (Lonza) and Nucleofector Kits for 
Primary Endothelial Cells or Nucleofector KitV (Lonza) according 
to the manufacturer’s instructions, using the program M-003 for ECs 
or A-023 for HEK cells.
For siRNA-mediated silencing, the day before oligofection, 
HUV ECs or HMECs were plated in six-well dishes at a concentration 
of 12 × 104 cells per well. Oligofection (Oligofectamine; Life Science) 
of siRNA duplexes was performed according to manufacturer’s proto-
cols. In brief, ECs were transfected twice (at 0 and 24 h) with 200 pmol 
siLuc (control) or siTRPM8, and 72 h after the second oligofection, 
HUV ECs were lysed or tested in functional assays.
The siTRPM8 sequence (5′-UAU CCG UCG GUC AUC 
UA(dTdT)-3′) is located at position 236 on the TRPM8 mRNA (Gen-
Bank accession no. AY328400). For control silencing, siRNA against 
Luciferase (siLuc; Eurogentec) was used.
The constructs used for this work were plasmids carrying the 
sequences of hTRPM8pcDNA4 (plasmid wild-type, Y905A, E906A; 
2 µg for transfection) already available in our laboratory, as previously 
described (Thebault et al., 2005a; Bidaux et al., 2015); GFP-Rap1-WT 
or human influenza agglutinin (HA)–tagged (1 µg for transfection; 
from G. Serini); GFP-Rap1-N17 (0.25–2.5 µg for transfection; from 
G. Serini); GFP-Rap1-V12 or HA-tagged (0.7–1.6 µg for transfection; 
from G. Serini), ER-DsRED (DsRed2 fused to the ER targeting se-
quence of calreticulin; 1 µg; from Takara Bio Inc.) as indicated in the 
text and figures, and pEGFP-RalGDS-RBD (from M. R. Philips, as pre-
viously characterized; Bivona et al., 2004)
Western blot analysis
Cells were seeded in Petri dishes with the appropriate medium and 
grown to a confluency of 80%. Before cell lysis, Petri dishes were 
kept on ice and washed in ice-cold PBS twice. Cells were lysate in the 
presence of RIPA buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 
1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) containing the 
following protease inhibitors: 2 mg/ml aprotinin, 1 mM Na orthova-
nadate, 0.1 mM PMSF, and 10 mM NaF. Lysates were centrifuged at 
4°C for 15 min at 10,000 g. Protein concentrations were determined 
using a bicinchoninic acid kit (Sigma-Aldrich) following the manufac-
turer’s instructions. Conditions for SDS-PAGE and Western blotting 
were assessed as previously described (Fiorio Pla et al., 2012b). Poly-
vinylidene fluoride membranes were properly blocked and then incu-
bated overnight with rabbit anti–TRPM8 (1:400 Alomone) or rabbit 
anti–TRPM8 (1:400; ab109308; Abcam), anti–Rap1 (1:1,000; Thermo 
Fisher Scientific), anti–Fak or anti–phospho-Fak (Ty397; 1:200; Santa 
Cruz Biotechnology, Inc.), and anti–β-actin (Sigma-Aldrich) anti-
bodies. The membrane was then washed with TBS containing 0.1% 
Tween 20 and incubated with the appropriate horseradish peroxidase–
conjugated antibodies (Santa Cruz Biotechnology, Inc.). Chemilu-
minescence assays were conducted using the SuperSignal West Pico 
chemiluminescent substrate (Thermo Fisher Scientific). To quantify 
differences in protein expression, the ratio between TRPM8 and actin 
expression or between phospho-Fak and Fak expression (each normal-
ized to actin) was evaluated
Immunoprecipitation assay
Cells were cotransfected with a his-tagged hTRPM8pcDNA4 plasmid 
(wild-type, Y905A, E906A), HA-tagged rap1. 48 h after transfection, 
cells were washed twice with PBS and incubated for 60 min on ice 
in lysis buffer (1% Triton X-100, 1% sodium deoxycholate, 150 mM 
NaCl, 10 mM NaKPO4, pH 7.2, and antiprotease cocktail; Sigma-Al-
drich). After centrifugation (12,000 g for 10 min at 4°C) of the lysates, 
protein concentration was determined by the BCA assay (Thermo 
Fisher Scientific), and equal amount of supernatants were incubated 
overnight at 4°C with 2 µg of a mouse anti–HA antibody (H3663; Sig-
ma-Aldrich) immobilized on protein A/G PLUS agarose beads (Santa 
Cruz Biotechnology, Inc.) in IP buffer (20 mM NaH2PO4 and 150mM 
NaCl, pH 8). The pellet was washed three times in IP buffer, resus-
pended in SDS sample buffer, heated at 37°C for 30 min, separated 
on 4–20% precast SDS-PAGE gels (Bio-Rad), and analyzed by immu-
noblotting using rabbit anti–HA (1:2,000; ab9110; Abcam) and rabbit 
anti–TRPM8 (1:400; ab109308; Abcam) antibodies.
Each experiment was repeated at least three times.
Biotinylation assay
The biotinylation assay was performed after homogenizing cells in 
1 ml lysis buffer as described previously (Gkika et al., 2010) using 
the NHS-LC-LC-biotin kit (Thermo Fisher Scientific). Biotinylated 
proteins were precipitated using neutravidin-agarose beads (Thermo 
Fisher Scientific). TRPM8 expression was analyzed by immunoblot-
ting of the precipitates (PM fraction) or of total cell lysates using an-
ti-TRPM8 antibody (Alomone).
PLA
Duolink in situ red starter kit goat/rabbit (Sigma-Aldrich) was used for 
this experiment. HMECs transfected or not with siTRPM8 were seeded 
at 20 × 103 cells per confocal FluoroDish (World Precision Instruments). 
Cells were fixed and permeabilized with 4% platelet activating factor 
for 10 min. After permeabilization, cells were incubated in the blocking 
buffer (provided with the kit) for 30 min at 37°C in a humidified cham-
ber. Cells were incubated with the primary antibodies diluted in the an-
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tibody diluents for 2 h at room temperature (goat anti–TRPM8 antibody, 
ABIN572229, 1:200; Antibodies-online; rabbit anti-Rap1, MA5-15052, 
1:200; Thermo Fischer Scientific). For the rest of the protocol, the man-
ufacturer’s instructions were followed. Recordings were performed by 
confocal imaging (LSM700; ZEI SS) using z-stack superposition (Zen 
2010 software; ZEI SS). Appropriate controls were performed by incu-
bating with both primary antibodies separately (Fig. S5 G).
RNA isolation and real-time PCR
Total RNA was isolated using TRIzol Reagent (Thermo Fisher Scien-
tific) according to the manufacturer’s protocol and quantified spectro-
photometrically (Nanodrop ND-1000). For gene expression analysis, 
quantitative real-time PCR was performed. In brief, first-strand cDNA 
was produced from 200 ng total RNA using the High Capacity cDNA 
Reverse Transcription kit (Applied Biosystems).
Quantitative real-time PCR experiments were performed in 20-µl 
reaction mixture containing 5 ng cDNA template, the sequence-specific 
oligonucleotide primers (purchased from MWG-Biotech, Eurofins Ge-
nomics) and the Power SYBR Green PCR Master Mix (Applied Biosys-
tems). 18s was used to normalize RNA inputs. The following TRPM8 
sequence-specific oligonucleotide primers were used: forward, 5′-ACA 
CCC AAC CTG GTC ATC TCA-3′; reverse, 5′-TGC CCC TTT AGA CTG 
AGC GA-3′; 18S ribosomal RNA: forward, 5′-CAG CTT CCG GGA 
AAC CAA AGTC-3′; reverse, 5′-AAT TAA GCC GCA GGC TCC ACTC-
3′. The comparative Ct method was adopted for relative quantification 
of gene expression and 18s was used to normalize RNA inputs. Fold-
change expression respect to HMECs was calculated for all samples.
Migration assay
Cell motility was investigated by the migration of cells into a scratch 
“wound” made on a confluent monolayer as previously described 
(Pupo et al., 2011). Cells were grown to confluency in 24-well culture 
plates coated with 1% gelatin. Cell monolayers were allowed to rest for 
12 h in DMEM containing 2% FCS and a “wound” made by scraping 
the middle of the cell monolayer with a P10 pipette tip. Floating cells 
were removed by washing twice with PBS, and the cell monolayer was 
treated with test conditions (see Results). Cells did not undergo any 
significant degree of cell division during the experiments. Experiments 
were done using a Nikon Eclipse Ti-E microscope with a 4× objec-
tive. Cells were kept at 37°C and 5% CO2 for all experiments; a photo 
was taken every 2 h using MetaMorph software. Cell migration into a 
wound was measured with MetaMorph software. Cell migration was 
assessed by measuring the distance between the two sides of the wound 
at each time point. Three separate wells were used for each condition; 
in each well, at least six fields were analyzed for each condition. At 
least three independent experiments were performed for each question 
asked. Obtained data were further analyzed using Excel to calculate the 
percentage of migration for each wound (difference of distances be-
tween cell fronts at two subsequent time points over distance at time = 
0 h), and the percentage mean value for each condition was then calcu-
lated. Relative migration was calculated, evaluating the propagation of 
errors for the SEM. A nonparametric unpaired Wilcoxon–Mann-Whit-
ney test was used to assess statistical significance.
In vitro vascular network formation
The in vitro formation of capillary-like structures was studied on 
growth factor–reduced Matrigel (BD) in 24-well plates. Cells (3.5 × 
104 cells/well) were seeded onto a Matrigel coating in EndoGRO MV-
VEGF complete medium and treatment conditions. Each experimental 
condition was performed in duplicate, and at least six fields for each 
well were analyzed for each independent experiment. At least three 
independent experiments were performed for each question asked. 
Cell organization on Matrigel was periodically observed with a Nikon 
Eclipse Ti E microscope using a Nikon Plan 10×/0.10 NA objective. 
Cells were kept at 37°C and 5% CO2 during the experiment. Images 
were acquired at 2-h time intervals using MetaMorph software.
Image analysis was performed with ImageJ software. Images 
at 18 h of treatment were analyzed. The number of nodes (intersec-
tions formed by at least three detectable cells) and total tubule length 
(aligned cells connecting nodes) were measured for each field. The 
number of nodes and tubule length were normalized to maximum val-
ues and their sum for each condition was used to express the degree of 
organization into “capillary-like” structures in terms of arbitrary units. 
Graphs represent three independent experiments; error bars show SEM. 
A nonparametric unpaired Wilcoxon–Mann-Whitney test was used to 
assess statistical significance.
HUV EC sprouting assay
HUV EC collagen sprouting assay was performed as previously de-
scribed (Korff et al., 2004). In brief, confluent monolayers of HUV ECs 
were trypsinized and suspended in M199 complete culture medium 
plus 20% of M199 medium containing 2% methylcellulose (Metho-
cel Stock medium) and seeded in nonadherent round bottom 96-well 
plates. Under these conditions, all suspended cells contribute to the 
formation of a single spheroid per well of defined size and cell number 
(800 cells per spheroid). Spheroids were cultured for 24 h and used 
for the corresponding experiments. HUV EC spheroids were suspended 
in Methocel Stock medium, enriched with 40% FCS, with or without 
different stimuli, and mixed with a volume of diluted collagen stock 
solution, previously prepared in ice (Korff et al., 2004). The spheroid 
containing collagen was rapidly transferred into a 48-well plate and 
allowed to polymerize (15 min) at 37°C after which 400 µl of M199 
poor were added in each well. The plate was incubated at 37°C, 5% 
CO2, and 100% humidity for 24 h. The following molecules were used 
for the stimulation of HUV EC spheroids: 10 ng/ml VEGF 165 (R&D 
Systems), 10 µM icilin, and 10 ng/ml VEGF 165 + 10 µM icilin.
HUV EC spheroids in 3D collagen matrix were fixed with 4% 
PFA for 10 min at room temperature and examined at 24 h after stim-
ulation. Spheroids were imaged under bright field using the DMI 4000 
B inverted microscope (Leica Biosystems). Analysis of the total area 
of sprouts per spheroid was performed on phase contrast images using 
the ImageJ software package applying a fix threshold and subsequently 
measuring the spheroid area
Results are shown as mean ± SEM of four independent assays 
(total n = 60 spheroids per experimental condition), one of which is 
shown in the figure’s panel. Results were analyzed by a two-tailed het-
eroscedastic Student’s t test (*, P ≤ 0,05; **, P ≤ 0,01; and ***, P ≤ 0,001).
Impedentiometric analysis
Impedentiometric analysis was performed to measure cell impedance 
with the RTCA DP Analyzer xCELLigence System (Roche). Cells 
were seeded onto a 1 μg/ml FN coating on a 16-well “E-Plate” that 
incorporates a sensor electrode array, allowing cells in the well to 
be monitored and assayed.
Adhesion assay
Cell adhesion was evaluated on 96-well plates using a coating of 1% 
gelatin or 0.25–2.0 µg/ml FN. Cells were detached using trypsin for 
3 min, carefully counted and seeded at 3,000 cells per well in 100 µl 
growth medium (EndoGRO-MV-VEGF for HMECs and BTECs or 
complete M199 medium for HUV ECs) under different conditions (see 
Results). It should be noted that the medium was not depleted for FN.
The 96-well plates were kept at 37°C and 5% CO2 for 15 min and 
then washed twice with PBS. Cells were fixed in 4% PFA for 15 min 
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and then washed twice with PBS. To stain cell nuclei, 1 µM DAPI was 
used for 15 min at 37°C.
Image acquisition was performed using a T-E microscope 
(Nikon) with a 4× objective and cell nuclei counted using the automatic 
cell count tool of ImageJ.
At least eight wells for each condition were analyzed in each 
independent experiment. At least three independent experiments were 
performed. A nonparametric unpaired Wilcoxon–Mann-Whitney test 
was used to assess statistical significance.
Haptotaxis assay
Haptotaxis assays were performed on 24-well plates containing ECs 
seeded onto 8-µm-pore membrane cell culture inserts (Corning), whose 
bottoms were coated with 1 µg/ml FN. After 24 h of the same growth 
medium (EndoGRO-MV-VEGF), 10 µM icilin was added to both the 
top and bottom chambers (to exclude chemotactic migration); control 
wells received no treatment. After 6 h, ECs on the underside of the in-
sert were stained with Hoechst dye. Image acquisition was performed 
using a Nikon T-E microscope with a 4× objective, and cell nuclei were 
counted using the automatic cell count tool of ImageJ. Each experimen-
tal condition was performed in duplicate, and at least six fields for each 
well were analyzed for each independent experiment. At least three 
independent experiments were performed for each question asked. A 
nonparametric unpaired Wilcoxon–Mann-Whitney test was used to as-
sess statistical significance.
Integrin activation immunofluorescence assay
80,000 HUV ECs per slide were plated on 0.17-mm glass coverslips pre-
coated with 3 µg/ml FN. The day after, the medium was replaced with 
200 µl of an icilin treatment solution (10 µM icilin in M199 complete 
medium), and cells were treated for 15 or 30 min at 37°C. After the 
required time, the treatment was replaced with a solution containing the 
anti–β1-integrin antibody (10 µg/ml 9EG7 rat BD [1:50] in M199 com-
plete medium), and cells were treated for 10 min at 37°C. Cells were 
washed once with 1× PBS and fixed with a solution PFA 2% in PBS for 
10 min at room temperature. Cells were washed and permeabilized in 
0.1% Triton 1× PBS for 2 min on ice and incubated with the appropri-
ate Alexa Fluor–tagged secondary antibody (1:400 donkey anti–rat 488 
and 1:10,000 DAPI Alexa Fluor; Thermo Fisher Scientific).
Cells were analyzed by using a TCS SPE II confocal laser-scan-
ning microscope (Leica Biosystems) using LAS AF software (Leica Bio-
systems) for image acquisition. Acquisition was performed by adopting 
laser power, gain, and offset settings that allowed us to maintain pixel in-
tensities (grayscale) within the 0 to 255 range and hence avoid saturation.
Analysis of confocal images was performed using the ImageJ 
software package measuring corrected total cell fluorescence as inte-
grated density − (area of selected cell × mean fluorescence of back-
ground readings) (Burgess et al., 2010).
Results are the mean ± SEM of 15 cells per experimental condi-
tion, one of which is shown in a figure panel. Results were analyzed by 
a two-tailed heteroscedastic Student’s t test (*, P ≤ 0.05; **, P 
≤ 0.01; ***, P ≤ 0,001).
Active Rap1 pull-down and detection assay
A pull-down and detection assay for active Rap1 was performed using 
the Active Rap1 Pull-Down and Detection kit from Thermo Fisher Sci-
entific following the manufacturer’s instructions.
The detection of GTP-bound Rap1 GTPase was obtained through 
specific protein interactions with the RalGDS protein–binding domain.
At least three independent experiments were performed for each 
question asked. A nonparametric unpaired Wilcoxon–Mann-Whitney 
test was used to assess statistical significance.
GST-fusion proteins and pull-down assay
TRPM8 N- and C-terminal tail GST-fusion proteins were produced and 
purified as described previously (Gkika et al., 2015). GST-fused puri-
fied proteins were then incubated with HEK cell lysates transfected 
with pEGFP-RAP-1, pEGFP-RAP-1N17, or pEGFP-RAP-1V12 plas-
mids (reference Guido). For the direct interaction assay, the coding se-
quence of RAP-1-WT, RAP N17, and RAP V12 were subcloned in the 
pCMV TNT vectors (Promega) as EcoR1–Not1 fragments to produce 
them in vitro. Subsequently, Rap-WT and mutant proteins were trans-
lated in vitro using the TNT Quick Coupled Transcription/Translation 
Systems kit (Promega) and the FluoroTect GreenLys in vitro Transla-
tion Labeling System (Promega) as per the manufacturer’s instructions. 
For GST pull-down experiments performed with Rap1-WT loaded with 
GDP and GTP, in vitro translated Rap1-WT was incubated with 10 mM 
EDTA followed by 1 mM GDP or 100 μM GTPγS for 30 min at 30°C 
with constant agitation. The sample was then placed on ice, 60 mM 
MgCl2 was added, and the sample was vortexed.
Cell lysates or in vitro translated proteins were incubated over-
night at 4°C together with the purified GST-fusion proteins. Subse-
quently, beads were washed extensively and bound proteins were 
eluted with SDS-PAGE loading buffer, separated on 4–20% wt/vol 
SDS-PAGE gels, and visualized by fluorescence imaging (Bio-Im-
ager 600; GE Healthcare).
Calcium imaging
Cells were grown on glass gelatin-coated coverslips (gelatin coating 
was avoided for experiments using Tyrode physiological solution with-
out Ca2+) at a density of 5,000 cells/cm2 for 24 to 48 h. 2 to 5 h before 
experiments, cells were starved in DMEM with 0% FCS. Cells were 
next loaded (45 min at 37°C) with 2 µM Fura-2 AM (Invitrogen) for 
ratiometric cytosolic Ca2+ ([Ca2+]i) measurements as previously de-
scribed (Fiorio Pla et al., 2010, 2012b). During the experiments, cells 
were continuously bathed with a microperfusion system.
Fluorescence measurements were performed using a Poly-
chrome V spectrofluorometer (TILL Photonics) attached to a Nikon 
TE-2000-S (Nikon) microscope and Metafluor Imaging System (Mo-
lecular Devices) for image acquisition using 3-s intervals. During ex-
periments, cells were maintained in a standard extracellular solution of 
the following composition: 145 mM NaCl, 5 mM KCl, 2 mM CaCl2, 
1 mM MgCl2, 10 mM Hepes, and 10 mM glucose (NaOH to pH 7.35). 
Cells were continuously bathed with a microperfusion system. Each 
fluorescent trace (340/380 nm ratio) represents one ROI corresponding 
to cells in the chosen image field.
Peak amplitude (fluorescence intensity ratio, measured at 510 
nm) was determined by the difference between the maximum and 
minimum values of fluorescence intensity before reaching the peak it-
self. For the estimation of peak amplitude, only responses that had a 
ΔEm340/380 >0.02 were considered.
Electrophysiology
BTEC or BTEC-TRPM8 expressing macroscopic membrane ion cur-
rents were recorded at 37°C or 22°C using the patch-clamp technique 
in its whole-cell configuration. The currents were acquired using a 
PC-9 amplifier (HEKA) and analyzed offline using Origin software 
(OriginLab Corporation). The extracellular solution (osmolarity 310 
mosM/l) contained 150 mM NaCl, 5 mM KCl, 10 mM Hepes, 10 mM 
glucose, 1 mM MgCl2, and 2 mM CaCl2, pH 7.3 (adjusted with NaOH). 
The intracellular pipette solution (osmolarity 290 mosM/l) contained 
140 mM CsCl, 10 mM Hepes, 8 mM EGTA, 1 mM MgCl2, and 4 mM 
CaCl2 (100 nM free Ca2+), pH 7.2 (adjusted with CsOH). Patch pipettes 
were fabricated from borosilicate glass capillaries (World Precision In-
struments). The resistance of the pipettes varied between 3 and 5 MΩ. 
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Necessary supplements were added directly to the respective solutions 
in concentrations that would not significantly change the osmolarity. 
Changes in the external solutions were performed using a multibarrel 
puffing micropipette with common outflow that was positioned in close 
proximity to the cell under investigation. During the experiment, the 
cell was continuously superfused with the solution via a puffing pipette 
to reduce possible artifacts related to the switch from static to moving 
solution and vice versa. Cells were kept at 37°C. TRPM8 activity acti-
vated by imposing 22°C to bath solution was recorded, followed by 
application of 10  µM icilin and 500  µM menthol, to maximally 
stimulate TRPM8 channel.
Confocal analysis
HMECs grown on glass coverslips were fixed using 4% paraformal-
dehyde and incubated with PBS containing 0.2% BSA, 0.1% Tri-
tonX-100, for 30 min at room temperature to block nonspecific binding 
and to permeabilize the cells. They were then incubated overnight at 
4°C with PBS/5% nonimmunized serum containing a 1:200 dilution of 
the primary affinity-purified rabbit anti–TRPM8 polyclonal antibody 
(Alomone) and primary mouse anti–calnexin antibody. Cells were then 
washed with PBS and incubated with the secondary antibodies Alexa 
Fluor 546–labeled anti–rabbit IgG (dilution 1:2,000; Molecular Probes) 
or Alexa Fluor 488–labeled anti–mouse IgG (dilution 1:2,000; Molec-
ular Probes) diluted in PBS for 1 h at room temperature. After rinsing 
three times in PBS, cells were incubated in the presence of DAPI to 
stain nuclei, the slides mounted with Mowiol, and the distribution of la-
beled proteins was analyzed using an LSM 780 confocal immunofluo-
rescence microscope (ZEI SS) equipped with an argon laser and 405-nm 
diode. Control experiments were performed without primary antibody.
For live-cell imaging experiments, HMECs were nucleofected 
with 1 µg TRPM8-YFP, 1 µg ER-DsRed, or 1 µg Rap1-GFP or double 
transfected with 1 µg ER-DsRED and 1 µg Rap1-GFP or 1 µg Rap1N17-
GFP (as indicated in Results) or 0.5 1 µg GFP-RBDRalGDS. For the ex-
periments on TRPM8 down-regulation in HMECs, cells were first 
oligofected with siRNA against TRPM8 (siTRPM8) with a double 
pulse as described in Materials and methods. 48  h after the second 
pulse, HMECs were detached and nucleofected with 1 µg ER-DsRed 
and 1 µg Rap1-GFP or 0.5 1 µg GFP-RBDRalGDS. 24h after this second 
transfection, cells were imaged using an LSM 780 confocal microscope 
equipped with an argon laser. Live cells were kept at 37°C and 5% CO2 
for all experiments, and confocal images were acquired every minute 
using the “perfect focus” option to maintain the same focal plane. After 
1 h of acquisition, ECs were stimulated with 10 µM icilin or with a 
control solvent (DMSO 1:2,000 in PBS). Images were acquired using 
ZEN software and analyzed offline with ImageJ. For the analyses of 
GFP-RBDRalGDS, we measured relative cytoplasmic translocation as 
previously described (Bivona and Philips, 2005). In brief for each cell, 
we drown at least two ROIs of identical size around a region of cytosol 
without membrane encroachment and around an area of distinct PM 
fluorescence for each cell analyzed. The fluorescence intensity (I) was 
determined for these ROIs at each time point (Fig. S2 C). Relative cy-
toplasmic translocation (R) was calculated as R = (Ics − Im)/Im, where 
Im and Ics are the fluorescence intensities of the regions of interest of 
membrane and cytosol, respectively. A nonparametric unpaired Wil-
coxon–Mann-Whitney test was used to assess statistical significance. 
At least three independent experiments were performed for 
each experimental condition
Mathematical model
The role of TRPM8 channels in controlling Rap1-dependent EC migra-
tion and adhesion was studied with a multiscale hybrid mathematical 
approach. In particular, at the lowest molecular level, a system of re-
action-diffusion (RD) equations describes the spatiotemporal kinetics 
of the molecular variables of interest. A suitable version of the CPM, 
a mesoscopic spatial grid–based formalism (Glazier and Graner, 1993; 
Scianna and Preziosi, 2013), reproduced instead the dynamics of the 
cell as a whole, derived from an iterative minimization of the energy of 
cell deformation and stretching through stochastic fluctuations. These 
different submodels were then interfaced and integrated in a hybrid en-
vironment and directly impacted each other, with a constant interplay 
and flux of information between the different levels (see the next para-
graph for an exhaustive description of the model). Variations in cell 
morphology were quantified by evaluating the relative area of a cell, 
given by the ratio acell(t)/Acell, where acell(t) is the actual area of the cell 
and Acell is its initial area This value qualitatively also corresponded to 
the relative adhesion of cells under experimental conditions, especially 
in 2D computational settings (Scianna et al., 2013). Cell velocity was 
determined by the velocity of the cell center of mass, as described pre-
viously (Scianna et al., 2013). The mean values for cell velocity and 
relative area were evaluated over a timespan of 12 h.
Model hypothesis and considerations
The proposed multiscale hybrid theoretical approach is based on the 
following (minimal) set of assumptions, schematically represented in 
Fig. S2 B: (1) the mathematical model refers to the HMEC experimen-
tal model; (2) cell dynamics are modeled in 2D, using the quasi-3D 
approximation described previously (Marée et al., 2006); (3) the cell 
cytosolic region and the PM are explicitly reproduced, whereas the ER, 
because of its intricate reticular structure, is represented as a continu-
ous network of varying density within the cytosol (Fink et al., 2000); 
(4) we model both the basal and the icilin-induced activity of TRPM8; 
(5) TRPM8 channels are distributed in the cytosolic region in accor-
dance to the local density of the ER; (6) we keep track of the Rap1 
that is active (Ra present both in the cytosol and in the membrane) or 
inactive (Ri, localized only in the cytosol); (7) we introduce a further 
molecular variable, Ram, representing the complex Rap1-Riam-Talin-in-
tegrin-Fak localized in the PM; (8) Rap1 cycles between its active and 
inactive forms in the cytosol; (9) the membrane-bound Rap1-mediated 
assembly has a regulatory function of both cell adhesion and migration; 
and (10) TRPM8 inhibits Rap1 functions by sequestering the inactive 
RAP1-GDP-bound form. Such a sequestering activity is enhanced by 
ICI LIN stimulation but is already active in TRPM8 at the basal state.
Such a collection of model hypothesis are consistent with the 
experimental observations presented throughout the paper. This al-
lows us to provide coherent comparisons between in silico and in vitro 
outcomes and use the mathematical approach in a predictive manner, 
i.e., to determine the consequences in the cellular behavior of selected 
conditions, which would be hard to obtain by experimental setting 
manipulations. However, it is useful to remark that the theoretical ap-
proach does not incorporate each and every aspect and factor of the 
mechanisms involved in the problem of interest, as its derivation re-
lies upon simplification procedures. In this respect, we can claim that 
the mathematical model deals with a “clean” cellular system and that 
its outcomes and predictions therefore have to be observed with a 
qualitative point of view.
Model description
The simulation domain is a 2D regular lattice Ω ∈ R2, formed by identi-
cal closed grid sites x = (x,y). Each site is labeled by an integer number, 
σ(x) ∈ N+, that can be interpreted as a degenerate spin originally com-
ing from statistical physics (Ising, 1925; Potts, 1952). As classically 
adopted in CPMs, a neighboring site of x is denoted by x′ andits overall 
neighborhood by  Ω ′ x (i.e.,  Ω ′ x =  { x ′ ∈ Ω : x ′  is a neighbor of x } ). Fol-
lowing the CPM extension proposed previously (Scianna and Preziosi, 
[AQ9]
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2012), the EC is represented as a compartmentalized element, com-
posed of two subregions: a central cytosolic cluster and the surrounding 
PM. Each intracellular compartment consists of a set contiguous lattice 
sites sharing the same index σ(x). In particular, the cytosol is defined 
as  ∑ σ ( x ) =1 =  { x ∈ Ω : σ ( x ) = 1 } and the PM as  ∑ σ ( x ) =2 =  { x ∈ Ω : σ ( x 
) = 2 } . The cell resides in a matrix-like substrate that is finally repre-
sented by an extended and isotropically distributed element  ∑ σ ( x ) =0 =  { 
x ∈ Ω : σ ( x ) = 0 } (Fig. S2 A). At each time t, the effective energy of 
the cell, whose minimization establishes its dynamics, is determined by 
a Hamiltonian functional: H(t) = Hadhesion(t) + Hshape(t).
Hadhesion is the general extension of Steinberg’s differential adhe-
sion hypothesis (Steinberg, 1970; Scianna and Preziosi, 2013), which 
is differentiated in the contributions from either the generalized contact 
tension between the cytoplasm and the PM or the effective adhesion 
between the cell and the matrix-like substrate:  H adhesion ( t ) =  ∑ x, x ′ ∈ Ω ′ x  
J  Σ σ ( x ) =1 ,   Σ σ ( x ′ ) =2  +  ∑ x, x ′ ∈ Ω ′ x   J  Σ σ ( x ) =2 ,   Σ σ ( x ′ ) =0  ( t ) , where the coefficients J’s ∈ R are bind-
ing forces per unit area and are obviously symmetric with respect to 
their indices. In particular, we fix a high negative bond energy  J  Σ 1 , Σ 2  to 
prevent the cell from fragmenting (Scianna and Preziosi, 2012; Scianna 
et al., 2013). The cell–substrate adhesiveness is instead assumed to be 
locally enhanced by the concentration of Rap1-mediated active integrin 
complexes in the PM, as  J  Σ σ ( x ) =2 ,   Σ σ ( x ) =0  ( t ) =  J 0  e 
−K R am ( x,t )  , where Ram(x,t) is 
the local amount of active integrin assemblies in the PM (compare Eq. 
4). Hshape models the geometrical attribute of the cell, written as a non-
dimensional relative deformation in the following quadratic form (see 
Scianna and Preziosi, 2013 for a more detailed explanation):
  H shape ( t ) =  λ el ( t ) (  a cell ( t ) −  A cell  _________ a cell ( t )  ) 
2
 , 
where acell(t) = Σx: σ(x) = {1,2} is the cell actual area and Acell is its 
initial value. λel(t) ∈ R+ is a mechanical modulus in units of energy 
relative to the cell deformability/elasticity; i.e., the ease with which the 
individual is able to remodel. Following experimental considerations 
suggesting a Rap1-mediated facilitation of cytoskeletal reorganiza-
tions, we set  λ el ( t ) =  λ 0  e −K R am ( cell,t )  , where λ0 is an intrinsic cell resis-
tance to compression and  R am ( cell, t ) =  ∑ x:σ ( x ) = { 1,2 }   R am ( x, t ) evaluates the 
total amount of active integrin complexes within the cell (a similar re-
lation is used in Scianna et al., 2011 for VEGF-activated vascular ECs 
during tubulogenic processes). The energy minimization algorithm 
consists of a modified Metropolis method for Monte Carlo–Boltzmann 
dynamics (Metropolis, 1953; Graner and Glazier, 1992; Glazier and 
Graner, 1993; Scianna and Preziosi, 2013). Procedurally, at each time 
step t, called Monte Carlo step (the basic unit of time of the model), a 
lattice site xs (s for source) is selected at random and attempts to copy 
its spin, σ(xs), into one of its unlike neighbors,  x t ∈  Ω ′ x : σ ( x t ) ≠ σ ( x s 
) (t for target), also randomly selected. In particular, if σ(xs) σ(xs) = 
2 and σ(xt) = 0, the cell is protruding, whereas if σ(xs) = 0 and σ(xt) 
= 2, the cell is retracting. Finally, if σ(xs) = 1, the cell is reorganizing. 
Such a trial spin update is accepted with a Boltzmann-like probability 
function P[σ(xs) → σ(xt)], which takes into account also of the inter-
cellular chemical state:
P[σ(xs) → σ(xt)] (t) = 
  
⎧
 
⎪⎨
⎪⎩
tanh  ( Ψ  R am ( x s , t ) ) min  { 1,  e − ΔH _Ψ R am ( x s ,t )  } when cell is protruding;
     min  { 1,  e −ΔH }                                       when cell is reorganizing; 
 
e −Ψ R am ( x t ,t )                                                 when cell is retracting,
   
 (1)
where ΔH is the net difference of the system energy caused by the pro-
posed change of domain configuration, Ram is, as seen, the local amount 
of active integrin complexes and ψ is a proper constant. In particular, in 
Eq. 1, we model the experimentally provided Rap1 influence in filopo-
dia extensions and membrane ruffles.
The inactive form of Rap1 satisfies an RD equation of the form:
  
∂  R i  ___∂  t =  D R  Δ  R i +  k of f R   R a −  k o n R   R i − Γ  R i ρ in   Σ 1 (2)
where DR represents the constant cytosolic diffusion of Rap1 and  k o n R  
and  k of f R  its kinetics rate of activation and inactivation, respectively. The 
last term at the right-hand side of the equation describes instead the 
GDI-like effect of TRPM8 in sequestering the inactive form of Rap1: 
in particular,  ρ ( x ) =  e −d ( x, x CM )  , where xCM is the cell center of mass, mea-
sures a normalized local density of the ER, which, as reported from 
electron microscopy, increases in perinucear regions (Fink et al., 2000). 
Finally, Γ is a constitutive law that measures the sequestering rate of 
inactive Rap1 performed by TRPM8. In particular, Γvaries with the 
different experimental conditions as follows:
  Γ =  
⎧
 
⎪
⎨⎪
⎩
 k o n T  T                                      NO ICI LIN;
    
 k o n  T i   T                                      ICI LIN;
    k o n T  T ( 1 −   k o n T   _ 1 +  k o n T    R n17  _ 1 +  R n17 )    NO ICI LIN and Rap1-N17;  
 k o n  T i   T ( 1 −   k o n  T i    _ 1 +  k o n  T i     R n17  _ 1 +  R n17 )    ICI LIN and Rap1-N17. 
   
 (3)
In Eq. 3, T measures the homogeneous and constant-in-time local 
amount of TRPM8, which is given by the sum of endogenous and ex-
ogenous (added by transfection) channels, i.e., T = Ter + Tex.  k o n T  and 
k o n  T i      are the rate of sequestering of inactive Rap1 characterizing, re-
spectively, TRPM8 with a basal activity and icilin-activated TRPM8: 
in this respect, it is consistent to assume  k o n T  <    k o n  T i     (we are further 
assuming that ICI LIN stimulation analogously enhances the activity 
of all channels). Finally, Rn17 model the concentration of exogenous 
Rap1-N17 (experimentally obtained by the corresponding transfec-
tion), which is assumed, for the sake of simplicity, to be homogenous 
in the whole cell cytosol.
The dynamics of the active form of Rap1 are instead described by:
  
∂  R a  ___∂  t =  D R  Δ  R a −  k of f R   R a +  k o n R   R i +  k of f M   R am −  k o n M   R a  in   Σ 1 ∪  Σ 2 , 
where  k o n M  and  k of f M  represent the rate of assembly and disassembly of the 
membrane-bound integrin complexes (the other parameters have been 
already introduced in Eq. 2). Finally, the local amount of Rap1-medi-
ated integrin complexes is determined as
  
∂  R am  ____∂  t =  D  R am   Δ  R am −  k of f M   R am +  k o n M   R a  in   Σ 2 ,   (4)
where  D  R am    is a constant diffusion rate along the membrane.
Model parameter setting
The characteristic length of each lattice site is 1 µm. The lattice of the 
CPM and the discretized PDEs use the same resolution. One Monte 
Carlo time step corresponds to 0.1 s, and the same time step is used to 
numerically integrate the PDEs. Diffusion processes are integrated using 
an explicit Euler method, with sufficiently small time-steps to guarantee 
numerical stability and with no flux boundary conditions. A summary of 
the parameter values used in the model appears in Table 1; in particular, 
we have assembled a set of parameter estimates based on composite 
data deriving from various EC types. Parameters not directly correlated 
with biological quantities have been instead estimated by preliminary 
simulations. The behavior of the model is however fairly robust in large 
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regions of the space around our estimates, leading to confidence in the 
qualitative biological relevance of the results. Initially, the cell is a round 
cluster with a 35 µm diameter, with defined and homogeneous levels of 
active and inactive Rap1 (i.e., Ra,0,Ri,0, respectively). On the contrary, the 
initial intracellular amount of active integrin complexes is null.
The control condition of the theoretical model is Tpm = Tex = R17 = 
0, Ter = 0.2 µM (so that T = 0.2 µM and no icilin stimulation.
To predict the role played in sequestering inactive Rap1 by 
TRPM8 channels localized in the membrane, which have indeed a cy-
tosolic tail, we add in Eq. 2 the term  − k o n T   T pm  R i    ( − k o n  T i    T pm  R i in the 
case of ICI LIN stimulation), where Tpm is the concentration of mem-
brane-bound M8. This sink term holds only for the cytololic sites in 
contact with the PM (i.e., σ(x) = 1 and  ∃ x ′   ∈  Ω ′ x : σ (  x ′ ) = 2 .
Finally, to reproduce different amounts (and therefore dif-
ferent ratios) of TRPM8 localized in either the PM or ER, we vary 
Tpm and T, as indicated in the corresponding plots. In particular, the 
amount of ER TRPM8 is changed by keeping constant the level of 
endogenous channels (i.e., Ter = 0.2  µM) while modulating the 
amount of exogenous TRPM8.
Online supplemental material
Supplementary figures show controls on siRNA experiments (Fig. 
S1) as well as supporting figures for the experiments presented in 
Fig. 2. Fig. S2 C shows the quantification of GFP-RBD PM recruit-
ment. Similarly, Videos 1 and 2 show representative cells recordings 
in of ECs expressing GFP-RBDRalGDS probe in control or cells si-
lenced for TRPM8. Representations of model cells as well as math-
ematical simulations experiments are shown in Fig. S3. Fig. S4 (A 
and B) shows Ca2+ imaging and electrophysiology experiments to 
prove TRPM8 channel function. Figs. S4 (C–E) and S5 show adhe-
sion experiments expressed as nonnormalized values. Controls for 
PLA experiments shown in Fig.  5 are reported in Fig. S5 G.  Fig. 
S6 shows complete immunoprecipitation and GST pull-down re-
sults in support of Fig. 5.
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Table 1. A summary of the parameter values used in the model
Parameter Value Units Reference
 J  Σ 1 ,  Σ 2  −20 Scianna and Preziosi (2012)
k 1 µM−1 Scianna and Preziosi (2012)
J0 4.5
λ0 4.5 Scianna et al. (2011)
Ψ 1 µM1
DR 1 µM2s−1 Marée et al. (2006)
 k of f R  1.5 s−1 Marée et al. (2006)
 k o n R  2 s−1 Marée et al. (2006)
 k o n T  1 µM−1s−1
 k o n  T i   2 µM
−1s−1
Ter 0.2 µM
Rn17 3a µM
Tex 1a µM
Tpm 0.2a µM
 k of f m  2.5 s−1
 k o n m  3.5 s−1
 D  R am  
0.1 µM2s−1 Marée et al. (2006)
Ra,0 2 µM
Ri,0 2.5 µM
aParameters that vary in the different sets of simulations.
[AQ18]
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Supplemental material
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Figure S1. (A) Surface biotinylation experiment performed on HMECs treated or not with 10 µM icilin. (B) The effect of menthol on HMEC migration, tub-
ulogenesis, and adhesion. (Bi) Plot of the percentage of migration of HMECs in control condition (growth medium) and treated with 250 µM menthol. The 
asterisk represents significant differences relative control untreated ECs (*, P < 0.05, Wilcoxon test). (Bii and Biii) Quantification of tubulogenesis (Bii) or 
cell adhesion (Biii) of HMECs in control or in the presence of 250 µM menthol. *, P < 0.05 (Wilcoxon test). (C) Efficiency of TRPM8 silencing (72 h after 
transfection) in HMEC or HUV EC transfected with siRNA specific for TRPM8 (siTRPM8). Bars represent the mean of five experiments ± SEM. The efficiency 
is measured as the percentage of remaining protein compared with cells transfected with a nontargeting siRNAs (siCtl = 100%) as measured by Western 
blot and quantified using ImageJ software. On the right is a representative picture of Western blot. Actin was used as a loading control.
[AQ19]
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Figure S2. (A) Representative photographs of a wound-healing assay taken at two different time points (t = 0 h, top; t = 8 h, bottom). HMECs or HUV 
ECs transfected with siRNA for TRPM8 200 nM (siTRPM8) or an siRNA for luciferase (CNT RL) 200 nM as a control were treated with control medium or 
10 µM icilin. Bars, 50 µm. (B) Representative photographs of the formation of capillary-like structure in Matrigel by HMECs (top) and BTECs (bottom) at 
18 h. HMECs transfected with an siRNA for TRPM8 (siTRPM8) or an siRNA for luciferase (CNT RL) were treated with control medium or 10 µM icilin. BTECs 
transfected with TRPM8 2 µg (TRPM8) or 2 µg of a GFP control vector (CNT RL) were treated with control medium or 10 µM icilin. (C) Quantification of 
GFP-RBD PM recruitment after icilin 10 µM stimulation. Retention of GFP-RBD to the cytosol at different time (t) can be given as the relative cytoplasmic re-
tention (R) for a given set of regions of interest as described in Materials and methods. Here, a and b and a′ and b′ are regions of interest that correspond, 
respectively to a patch of PM and an adjacent area of cytosol of identical size. For each time imaged (here t = 0, 2 min, and 10 min), the R factor for the 
cytosolic retention is calculated as R = (Ics − Im)/Im, where Im and Ics are the fluorescence intensities of the ROIs of membrane and cytosol, respectively, 
as previously described
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Figure S3. (A) Representation of the model cell, compartmentalized in the cytosolic region (Σ1) and in the PM (Σ2). The extracellular medium is instead 
identified by spin σ = 0. (B) Diagram of the simplified intracellular cascades included in the model. Rap1 cycle can be inhibited by TRPM8 channels by 
sequestering the inactive Rap1 form. Active Rap1 mediates the assembly of membrane-bound integrin complexes that enhance cell adhesion and motility. 
(C) Wind-rose graphs (Ci) and corresponding quantification (Cii) showing 10 migratory tracks (over a time span of 12 h) of simulated cells in the absence 
or in the presence of basal TRPM8 levels (0.2 µM). Black circles represent the ending location of cell center of mass. (D) Effect of different cellular locations 
and quantity of TRPM8 in mean velocity of a simulated cell. In particular, we vary both the total amount of TRPM8 and the ratio between its ER and PM 
expression. The values are means over 100 simulations. Error bars show standard deviations.
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Figure S4. (A) Time course of mean intracellular Ca2+ concentration in control (CNT RL) and TRPM8 transfected BTECs. ECs were perfused with 10 µM icilin 
or 100 µM ATP as a positive control. (B) Representative traces of 10 µM icilin– and 500 µM menthol-evoked currents recorded on BTECs or BTECs overex-
pressing TRPM8. (C) Quantification of adhesion to FN of HMECs overexpressing TRPM8 (HMEC/TRPM8) or not (HMECs), in the presence or absence of 
icilin. *, P < 0.05 (Wilcoxon–Mann-Whitney test). (D) Quantification of adhesion assays on FN coating of HMECs transfected with 0.7, 1.6 µg Rap1V12 
and in a control condition treated or not with 10 µM icilin. *, P < 0.05 (Wilcoxon test).The data are shown as relative adhesion normalizing treatment with 
icilin to the no-treatment condition. (E) Quantification of adhesion assays on FN coating of HMECs transfected with 0.7, 1, and 1.6 µg Rap1N17 or 
Rap1V12 plasmids and in control condition. *, P < 0.05 (Wilcoxon test). The data are shown as relative adhesion normalizing to control.[AQ20]
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Figure S5. (A) Quantification of adherent HMECs treated or not with 10 µM icilin on plates coated with 0, 0.25, 0.5, and 1.0 µg/ml FN. *, P < 0.05 
(Wilcoxon–Mann-Whitney test). (B) Quantification of haptotaxis of HMECs treated or not with 10 µM icilin on 1 µg/ml FN or control substrate. *, P < 0.05 
(Wilcoxon–Mann-Whitney test). (C) Quantification of adhesion to FN of HMECs silenced for TRPM8 (HMEC/siTRPM8) or not (HMECs), in the presence or 
absence of icilin. (D) Quantification of adhesion to FN of HUV ECs silenced for TRPM8 (HUV EC/siTRPM8) or not (HUV ECs), in the presence or absence 
of icilin. (E) Quantification of adhesion to FN of BTECs overexpressing TRPM8 (BTEC/TRPM8) or not (BTECs), in the presence or absence of icilin. *, P < 
0.05 (Wilcoxon–Mann-Whitney test). (F) TRPM8 acts through the α5β1 integrin signaling pathway. Quantification of adhesion to FN of HMECs treated (or 
not) with icilin, the integrin-activating 9EG7 antibody, both in the presence of 0.1 mM MnCl2. *, P < 0.05 (Wilcoxon–Mann-Whitney test). Data represent 
adhesion normalized to the control untreated condition. All data represent not normalized cell adhesion/field. (G) Negative controls for PLA experiments. 
PLA was performed incubating cells with both primary antibodies separately. No PLA puncta are detectable.
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Figure S6. The GDP-bound form of Rap1 interacts directly with the TRPM8 N terminus. (A) Representative immunoprecipitation experiments. Expression 
vectors encoding Rap1-WT-HA were transfected into HEK-overexpressing TRPM8 cells. Cell lysates were immunoprecipitated (IP) with an anti–HA antibody 
and immunoblotted with antibodies against TRPM8 and HA. (B) Immunoblot against GFP (top) showing the GST pull-down assay between HEK cells lysate 
overexpressing GFP-Rap1 (left), GFP-Rap1-N17 (middle), or GFP-Rap1-V12 (right) and GST or GST fused to the TRPM8 N-terminal tail (GST-Nt) or C-termi-
nal tail (GST-Ct). 10% of cell lysates were used for the input of the GST pull-down (top panel). Anti- GST or anti-GFP Antibodies were used to visualize the 
interaction of Rap with GST-fused N- and C-terminal tail. (C) GST pull-down assay of in vitro translated Rap1WT, Rap1-N17 or Rap1-V12 using FluoroTect 
and GST or GST fused to the TRPM8 N-terminal tail (GST-Nt) or C-terminal tail (GST-Ct). 10% of the in vitro translated Rap1 was used for the input of the 
GST pull-down (top). Bodipy-FL-stained gel are shown for the expression of Rap1, whereas GST antibody was used to visualize the GST-fused N- and 
C-terminal tail. (D) The GST pull-down assay was repeated by loading in vitro translated RAP1-WT with 1 mM GDP (left) or 0.1 mM GTP (right). Anti-GST 
or anti–Rap1 antibodies were used to visualize the interaction of Rap with GST-fused N- and C-terminal tail. All the gels are representative of at least three 
independent experiments.
Video 1. Live-cell imaging by confocal microscopy of ECs expressing GFP-RBDRalGDS probe in control (siCNT RL). The video shows 
EC expressing GFP-RBDRalGDS. 10 µM icilin was added after 10 min. The video was acquired by capturing one frame per minute.
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Video 2. Live-cell imaging by confocal microscopy of ECs expressing GFP-RBDRalGDS probe in cells silenced for TRPM8 (siTRPM8). 
The video shows EC expressing GFP-RBDRalGDS. 10  µM icilin was added after 10 min. The video was acquired by captur-
ing one frame per minute.
